1
|
Cissé C, Cissé L, Samassékou O, Ba HO, Coulibaly T, Diallo SH, Diallo S, Taméga A, Diarra S, Maïga AB, Kané F, Yalcouyé A, Bocoum A, Dembélé ME, Traoré O, Simaga A, Traoré SF, Keita M, Fischbeck K, Traoré M, Guinto CO, Landouré G. Clinical, paraclinical and genetic aspects of autosomal recessive cerebellar ataxias (ARCA) in Mali. Mali Med 2022; 37:61-65. [PMID: 36919030 PMCID: PMC10009943] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 03/16/2023]
Abstract
Introduction Autosomal recessive cerebellar ataxias (ARCA) are a group of rare and heterogynous neurodegenerative diseases mainly characterized by unbalance and walking difficulty and movement incoordination. Objectives To clinically and paraclinically characterize ARCA in the department of Neurology at the Teaching Hospital of Point G and identify the underlying genetic defect. Patients and method We have conducted a longitudinal and prospective study from January 2018 to December 2020. Patients with ARCA phenotype seen in the Department of Neurology at the Teaching Hospital of Point "G" were enrolled. Results We have enrolled 7 families totaling 13 patients after giving an informed verbal and written consent. The sex ratio was 2.2 in favor of males, Kayes region and Fulani ethnic group were respectively the most represented region and ethnic group.Walking difficulty represented the major symptom followed by loss of vibration and joint sense, nystagmus, dysarthria and skeletal deformities. Alpha-foetoprotein level was high in one patient. Genetic testing confirmed Friedreich ataxia in one family and was not conclusive in 4 families. Conclusion This study showed that ARCA are not uncommon in Mali and genetic testing is crucial to confirm the diagnosis.
Collapse
Affiliation(s)
- Cak Cissé
- Faculté de Médecine et d'Odontostomatologie, USTTB, Bamako, Mali
| | - L Cissé
- Service de Neurologie, Centre Hospitalier Universitaire du Point G, Bamako, Mali
| | - O Samassékou
- Faculté de Médecine et d'Odontostomatologie, USTTB, Bamako, Mali
| | - H O Ba
- Faculté de Médecine et d'Odontostomatologie, USTTB, Bamako, Mali
- Service de Cardiologie, Centre Hospitalier Universitaire de Gabriel Touré, Bamako, Mali
| | - T Coulibaly
- Faculté de Médecine et d'Odontostomatologie, USTTB, Bamako, Mali
- Service de Neurologie, Centre Hospitalier Universitaire du Point G, Bamako, Mali
| | - S H Diallo
- Faculté de Médecine et d'Odontostomatologie, USTTB, Bamako, Mali
- Service de Neurologie, Centre Hospitalier Universitaire de Gabriel Touré, Bamako, Mali
| | - S Diallo
- Service de Neurologie, Centre Hospitalier Universitaire de Gabriel Touré, Bamako, Mali
| | - A Taméga
- Faculté de Médecine et d'Odontostomatologie, USTTB, Bamako, Mali
| | - S Diarra
- Faculté de Médecine et d'Odontostomatologie, USTTB, Bamako, Mali
- Neurogenetics Branch, NINDS, NIH, Bethesda, MD, H3Africa consortium
| | - A B Maïga
- Service de Neurologie, Centre Hospitalier Universitaire du Point G, Bamako, Mali
| | - F Kané
- Faculté de Médecine et d'Odontostomatologie, USTTB, Bamako, Mali
| | - A Yalcouyé
- Faculté de Médecine et d'Odontostomatologie, USTTB, Bamako, Mali
| | - A Bocoum
- Faculté de Médecine et d'Odontostomatologie, USTTB, Bamako, Mali
| | - M E Dembélé
- Faculté de Médecine et d'Odontostomatologie, USTTB, Bamako, Mali
| | - O Traoré
- Faculté de Médecine et d'Odontostomatologie, USTTB, Bamako, Mali
| | - A Simaga
- Institut Ophtalmologique Tropical de l'Afrique, IOTA
| | - S F Traoré
- Faculté de Médecine et d'Odontostomatologie, USTTB, Bamako, Mali
| | - M Keita
- Service d'ORL, Centre Hospitalier Universitaire de Gabriel Touré, Bamako, Mali
| | - K Fischbeck
- Neurogenetics Branch, NINDS, NIH, Bethesda, MD, H3Africa consortium
| | - M Traoré
- Service de Cytogénétique et de Biologie Reproductive, INSP, Bamako, Mali
| | - C O Guinto
- Faculté de Médecine et d'Odontostomatologie, USTTB, Bamako, Mali
- Service de Neurologie, Centre Hospitalier Universitaire du Point G, Bamako, Mali
| | - G Landouré
- Faculté de Médecine et d'Odontostomatologie, USTTB, Bamako, Mali
- Service de Neurologie, Centre Hospitalier Universitaire du Point G, Bamako, Mali
- Neurogenetics Branch, NINDS, NIH, Bethesda, MD, H3Africa consortium
| |
Collapse
|
2
|
Dembélé ME, Cissé L, Diarra S, Yalcouyé A, Taméga A, Bocoum A, Maïga AB, Diallo SH, Coulibaly T, Diallo S, Simaga A, Grunseich C, Kéita M, Coulibaly MB, Fischbeck KH, Maiga Y, Guinto CO, Landouré G. [Progressive myoclonic epilepsy in the department of neurology of the University Teaching hospital Point "G"]. Mali Med 2022; 37:17-21. [PMID: 36945313 PMCID: PMC10026847] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 03/23/2023]
Abstract
Background Progressive Myoclonic Epilepsy (PME) is a heterogeneous group of pathologies associating epileptic seizures and other neurological and non-neurological disorders. Objectives We aim to characterize patients with symptoms of PME and identify the underlying genetic disorder. Methods After informed consent, the patients seen in the protocol for hereditary neurological diseases and presenting signs of epilepsy without a secondary cause were clinically evaluated over a three-year period in the Department of Neurology of the CHU Point "G". EEG, brain imaging and laboratory tests were performed to consolidate our diagnosis. DNA was extracted for genetic analysis. Results 141 families including five families with PME totaling eight cases were enrolled. The predominant symptoms in our patients were myoclonus in 87.5% (N = 8), followed by GTCS and cognitive impairment in 50%, each. A notion of parental consanguinity was found in 60% and autosomal recessive transmission evoked in 80% (N = 5). The EEG was pathological in 62.5% and imaging showed ponto-cerebellar atrophy in 25% (N = 8). The combination of sodium valproate and clonazepam was the main treatment. One case of death was recorded. Conclusion We report cases of PME in Mali with a possibility of discovering new genes.
Collapse
Affiliation(s)
- M E Dembélé
- Faculte de médecine et d'odontostomatologie, Université des sciences, des techniques et des technologies de Bamako, Mali
| | - L Cissé
- Service de Neurologie, CHU du Point "G", Bamako, Mali
| | - S Diarra
- Faculte de médecine et d'odontostomatologie, Université des sciences, des techniques et des technologies de Bamako, Mali
- Neurogenetics Branch, NINDS, NIH, Bethesda, MD
| | - A Yalcouyé
- Faculte de médecine et d'odontostomatologie, Université des sciences, des techniques et des technologies de Bamako, Mali
| | - A Taméga
- Faculte de médecine et d'odontostomatologie, Université des sciences, des techniques et des technologies de Bamako, Mali
| | - A Bocoum
- Faculte de médecine et d'odontostomatologie, Université des sciences, des techniques et des technologies de Bamako, Mali
| | - A B Maïga
- Faculte de médecine et d'odontostomatologie, Université des sciences, des techniques et des technologies de Bamako, Mali
| | - S H Diallo
- Faculte de médecine et d'odontostomatologie, Université des sciences, des techniques et des technologies de Bamako, Mali
- Service de Neurologie, CHU de Gabriel Touré, Bamako, Mali
| | - T Coulibaly
- Faculte de médecine et d'odontostomatologie, Université des sciences, des techniques et des technologies de Bamako, Mali
- Service de Neurologie, CHU du Point "G", Bamako, Mali
| | - S Diallo
- Service de Neurologie, CHU de Gabriel Touré, Bamako, Mali
| | - A Simaga
- Institut d'Ophtalmologie Tropicale de l'Afrique, Bamako, Mali
| | - C Grunseich
- Neurogenetics Branch, NINDS, NIH, Bethesda, MD
| | - M Kéita
- Faculte de médecine et d'odontostomatologie, Université des sciences, des techniques et des technologies de Bamako, Mali
- Service d'ORL, CHU de Gabriel Touré, Bamako, Mali
| | - M B Coulibaly
- Malaria Research and Training Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | | | - Y Maiga
- Faculte de médecine et d'odontostomatologie, Université des sciences, des techniques et des technologies de Bamako, Mali
- Service de Neurologie, CHU de Gabriel Touré, Bamako, Mali
| | - C O Guinto
- Faculte de médecine et d'odontostomatologie, Université des sciences, des techniques et des technologies de Bamako, Mali
- Service de Neurologie, CHU du Point "G", Bamako, Mali
| | - G Landouré
- Faculte de médecine et d'odontostomatologie, Université des sciences, des techniques et des technologies de Bamako, Mali
- Service de Neurologie, CHU du Point "G", Bamako, Mali
- Neurogenetics Branch, NINDS, NIH, Bethesda, MD
| |
Collapse
|
3
|
Coulibaly K, Sanogo CO, Diallo A, Tambassi S, Traoré S, Djiré I, Keïta G, Diallo S, Berthé M. [Anatomical and Junctional results of total hip prosthesesat Kati University Hospital]. Mali Med 2022; 38:26-30. [PMID: 38506192] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 03/21/2024]
Abstract
INTRODUCTION Hip prosthetic surgery is a commonly performed procedure in orthopedic trauma. It has changed the prognosis of traumatic, degenerative and inflammatory hip diseases. OBJECTIVE The aim of this work was to evaluate the functional and anatomical results of a series of total hip replacements in our department in the short and medium term and to compare them with the literature. PATIENTS AND METHODS This was a retrospective descriptive and analytical study of a series of 96 total hip replacements performed at the University Hospital of Kati, from January 2019 to December 2021. Functional discomfort was assessed in all patients before and after surgery. The prostheses used were of the Aston, AK, Surgival, Evolutus and Sharma types. The anatomical results were assessed by radiological criteria and the functional results by Postel Merle d'Aubigné criteria. RESULTS In our study, 96 hips were operated on by total prosthesis in 91 patients, including five bilateral cases. The patients were 49 men and 42 women. The average age was 46.9 years. Coxarthrosis associated with necrosis of the femoral head was the most frequent indication for arthroplasty (n=51), followed by femoral neck fracture (n=26). The inclination of the cup was anatomical in 73.3% of cases. The mean femoral offset was 44.1 mm with extremes of 26 and 59 mm. Cup anteversion was normal in 79.4% of cases. The mean preoperative PMA score increased from 5.2 (0 and 15) to 16.9 (4 and 18) late postoperatively. Our results were satisfactory in 89% of cases. CONCLUSION Total hip arthroplasty allows, in the vast majority of cases, to recover indolence and perfect functionality of the hip.
Collapse
Affiliation(s)
- Kalifa Coulibaly
- Service d'orthopédie traumatologie du CHU de Kati, Koulikoro/Mali
| | - C O Sanogo
- Service d'orthopédie traumatologie du CHU de Kati, Koulikoro/Mali
| | - A Diallo
- Service d'orthopédie traumatologie du CHU de Kati, Koulikoro/Mali
| | - S Tambassi
- Service d'orthopédie traumatologie du CHU de Kati, Koulikoro/Mali
| | - S Traoré
- Service d'orthopédie traumatologie du CHU de Kati, Koulikoro/Mali
| | - I Djiré
- Service d'orthopédie traumatologie du CHU de Kati, Koulikoro/Mali
| | - G Keïta
- Service d'orthopédie traumatologie du CHU de Kati, Koulikoro/Mali
| | | | - M Berthé
- Service d'orthopédie traumatologie du CHU de Kati, Koulikoro/Mali
| |
Collapse
|
4
|
Tolofoudie M, Somboro A, Diarra B, Sarro YS, Drame HB, Togo ACG, Sanogo M, Dembele A, Togun T, Nkereuwem E, Baya B, Konate B, Egere U, Traore M, Maiga M, Saliba-Shaw K, Kampmann B, Diallo S, Doumbia S, Sylla M. Isoniazid preventive therapy in child household contacts of adults with active TB in Bamako, Mali. Public Health Action 2021; 11:191-195. [PMID: 34956847 PMCID: PMC8680184 DOI: 10.5588/pha.21.0061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2021] [Accepted: 08/16/2021] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND AND OBJECTIVE Isoniazid preventive therapy (IPT) is known to reduce the risk of developing active TB in about 59% in children aged ⩽15 years. We assessed adherence, completion and adverse events among children who were household contacts of a newly diagnosed adult with smear-positive TB in Bamako, Mali. METHODS Children aged <15 years living in the same house with an adult smear-positive index case were enrolled in the study in the Bamako Region after consent was obtained from the parent or legal guardian. Adherence was assessed based on the number of tablets consumed during 6 months. RESULTS A total of 260 children aged <15 years were identified as household contacts of 207 adult patients with smear-positive TB during the study period. Among all child contacts, 130/260 (50.0%) were aged 0-4 years and were eligible for IPT; 128/130 (98.5%) were started on IPT and 83/128 (64.8%) completed with good adherence at the end of the 6 months, and without any significant adverse events. CONCLUSION We successfully implemented IPT with good acceptance, but low completion rate. The Mali National TB Program and partners should expand this strategy to reach more children in Bamako and the whole country and create greater awareness in the population.
Collapse
Affiliation(s)
- M Tolofoudie
- University Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - A Somboro
- University Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - B Diarra
- University Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - Y S Sarro
- University Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - H B Drame
- University Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - A C G Togo
- University Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - M Sanogo
- University Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - A Dembele
- Department of Paediatrics, University Teaching Hospital of Gabriel Toure, Bamako, Mali
| | - T Togun
- Vaccines and Immunity Theme, Medical Research Council Unit-The Gambia, Banjul, The Gambia
| | - E Nkereuwem
- Vaccines and Immunity Theme, Medical Research Council Unit-The Gambia, Banjul, The Gambia
| | - B Baya
- University Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - B Konate
- National Tuberculosis Control Program, Ministry of Health and Public Hygiene, Bamako, Mali
| | - U Egere
- Vaccines and Immunity Theme, Medical Research Council Unit-The Gambia, Banjul, The Gambia
| | - M Traore
- Health Referral Center Five, Ministry of Health and Social Development, Bamako, Mali
| | - M Maiga
- Center for Innovation in Global Health Technology, Northwestern University, Chicago, IL, USA
| | - K Saliba-Shaw
- Collaborative Clinical Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Bethesda, MD, USA
| | - B Kampmann
- Vaccines and Immunity Theme, Medical Research Council Unit-The Gambia, Banjul, The Gambia
| | - S Diallo
- University Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - S Doumbia
- University Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - M Sylla
- Department of Paediatrics, University Teaching Hospital of Gabriel Toure, Bamako, Mali
| |
Collapse
|
5
|
Coulibaly T, Ouabo AJ, Landouré G, Bah HO, Cissé L, Diallo SH, Diallo S, Samassékou O, Maïga AB, Kané F, Yalcouyé A, Taméga A, Bocoum A, Dembélé ME, Témé A, Sidibé CO, Cissé AK, Traoré O, Traoré M, Guinto CO. [Clinical and laboratory features of recessive Limb Girdle Muscular dystrophies in the Department Neurology of University Hospital of Point G]. Health Sci Dis 2021; 22:24-28. [PMID: 34824573 PMCID: PMC8612446] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
INTRODUCTION Limb-Girdle Muscular dystrophies (LGMD) is a group of inherited diseases characterized by predominantly proximal and limb muscle weakness. These are rare diseases that have not been well studied in sub-saharan Africa. The aim of our was the clinical and paraclinical characterization of patients with recessive LGMD at the Department of Neurology of the Teaching Hospital of Point G. PATIENTS AND METHODS We conducted a longitudinal prospective study which took place from March 2014 to May 2019. Patients with recessive LGMD phenotype were enrolled. Sociodemographic, clinical and laboratory data were analyzed. RESULTS We enrolled 46 families (67 patients), i.e. a frequency of 16.7% among the neurodegenerative diseases seen in the service. Among them, 45.6% came from the Sikasso region. Autosomal recessive inheritance pattern was suspected in 67.4% of the families. Symptoms appeared mainly in the first decade of life. Proximal muscle weakness was found in almost all patients. Cardiac examination showed dilated cardiomyopathy in 4.5% of cases. CONCLUSION Limb-Girdle muscular dystrophy is a disabling disease that is found in Mali. Further study of these cases could elucidate the underlying genetic defects.
Collapse
Affiliation(s)
- Th Coulibaly
- Service de Neurologie, Centre Hospitalier Universitaire du Point G, Bamako, Mali
- Faculté de Médecine et d'Odontostomatologie, USTTB, Bamako, Mali
| | - A J Ouabo
- Service de Neurologie, Centre Hospitalier Universitaire du Point G, Bamako, Mali
| | - G Landouré
- Service de Neurologie, Centre Hospitalier Universitaire du Point G, Bamako, Mali
- Faculté de Médecine et d'Odontostomatologie, USTTB, Bamako, Mali
| | - H O Bah
- Faculté de Médecine et d'Odontostomatologie, USTTB, Bamako, Mali
- Service de Cardiologie, Centre Hospitalier Universitaire de Gabriel Touré, Bamako, Mali
| | - L Cissé
- Service de Neurologie, Centre Hospitalier Universitaire du Point G, Bamako, Mali
| | - S H Diallo
- Faculté de Médecine et d'Odontostomatologie, USTTB, Bamako, Mali
- Service de Neurologie, Centre Hospitalier Universitaire de Gabriel Touré, Bamako, Mali
| | - S Diallo
- Service de Neurologie, Centre Hospitalier Universitaire de Gabriel Touré, Bamako, Mali
| | - O Samassékou
- Faculté de Médecine et d'Odontostomatologie, USTTB, Bamako, Mali
| | - A B Maïga
- Service de Neurologie, Centre Hospitalier Universitaire du Point G, Bamako, Mali
| | - F Kané
- Faculté de Médecine et d'Odontostomatologie, USTTB, Bamako, Mali
| | - A Yalcouyé
- Faculté de Médecine et d'Odontostomatologie, USTTB, Bamako, Mali
| | - A Taméga
- Faculté de Médecine et d'Odontostomatologie, USTTB, Bamako, Mali
| | - A Bocoum
- Faculté de Médecine et d'Odontostomatologie, USTTB, Bamako, Mali
| | - M E Dembélé
- Faculté de Médecine et d'Odontostomatologie, USTTB, Bamako, Mali
| | - A Témé
- Service de Neurologie, Centre Hospitalier Universitaire du Point G, Bamako, Mali
| | - C O Sidibé
- Service de Neurologie, Centre Hospitalier Universitaire du Point G, Bamako, Mali
| | - A K Cissé
- Faculté de Médecine et d'Odontostomatologie, USTTB, Bamako, Mali
| | - O Traoré
- Faculté de Médecine et d'Odontostomatologie, USTTB, Bamako, Mali
| | - M Traoré
- Service de Cytogénétique et de Biologie Reproductive, INSP, Bamako, Mali
| | - C O Guinto
- Service de Neurologie, Centre Hospitalier Universitaire du Point G, Bamako, Mali
- Faculté de Médecine et d'Odontostomatologie, USTTB, Bamako, Mali
| |
Collapse
|
6
|
Wolf J, Ventouras LA, Menu P, Wójtowicz A, Zou M, Diallo S, Chassot Agostinho A, Tiedt R, Mina M. 101P The landscape of MET alterations in European cancer patients. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.381] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
7
|
Yalcouyé A, Diallo S, Diallo S, Landouré G, Bagayoko T, Maiga O, Fomba Z, Djibo D, Guinto C, Maiga Y. [Haemorrhagic Stroke after Snakebite Envenomation Resulting in Irreversible Blindness in a 6-Year-Old Child in Mali]. Med Trop Sante Int 2021; 1:mtsibulletin.2021.116. [PMID: 35586302 PMCID: PMC9022746 DOI: 10.48327/mtsibulletin.2021.116] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/16/2021] [Accepted: 07/09/2021] [Indexed: 11/06/2022]
Abstract
Introduction Snakebite envenomation can cause serious damage. Here, we report the case of a six-year-old male child bitten by a snake. Clinical description The child presented a gingivorrhagia, abdominal pain, bloody vomiting and severe headache from a snakebite. Neurological examination showed paralysis of the III cranial nerve associated with bilateral blindness and mydriasis, unreactive on the right. The brain scan revealed a left frontal hematoma. The course on antivenom was marked by the disappearance of clinical signs except blindness which remained 18 months after discharge. Discussion - Conclusion The hemorrhagic syndrome evoked viper bite. Blindness is rarely seen as a result of viperine envenomation. In our case, the presence of intracranial hypertension, absence of ocular lesions and scanner were in favor of compression of the optic nerves which resulted in permanent blindness.
Collapse
Affiliation(s)
- A. Yalcouyé
- Faculté de médecine et d'odontostomatologie, USTTB, Bamako, Mali
| | - S.H. Diallo
- Faculté de médecine et d'odontostomatologie, USTTB, Bamako, Mali,Service de neurologie, CHU Gabriel Touré, Bamako, Mali,*
| | - S. Diallo
- Service de neurologie, CHU Gabriel Touré, Bamako, Mali
| | - G. Landouré
- Faculté de médecine et d'odontostomatologie, USTTB, Bamako, Mali,Service de neurologie, CHU Point G, Bamako, Mali
| | - T. Bagayoko
- Faculté de médecine et d'odontostomatologie, USTTB, Bamako, Mali
| | - O. Maiga
- Faculté de médecine et d'odontostomatologie, USTTB, Bamako, Mali
| | - Z. Fomba
- Faculté de médecine et d'odontostomatologie, USTTB, Bamako, Mali
| | - D. Djibo
- Faculté de médecine et d'odontostomatologie, USTTB, Bamako, Mali,Service d'anesthésie réanimation, CHU Gabriel Touré, Bamako, Mali
| | - C.O. Guinto
- Faculté de médecine et d'odontostomatologie, USTTB, Bamako, Mali,Service de neurologie, CHU Point G, Bamako, Mali
| | - Y. Maiga
- Faculté de médecine et d'odontostomatologie, USTTB, Bamako, Mali,Service de neurologie, CHU Gabriel Touré, Bamako, Mali
| |
Collapse
|
8
|
Diarra B, Decroo T, Somboro A, Coulibaly G, Tolofoudie M, Kone M, Degoga B, Diallo F, Togo ACG, Sanogo M, Sarro YS, Cisse AB, Kodio O, Baya B, Kone A, Maiga M, Dao S, Maiga II, Murphy RL, Siddiqui S, Toloba Y, Konate B, Diakite M, Doumbia S, Van Deun A, Rigouts L, Diallo S, de Jong BC. Fluorescein diacetate and rapid molecular testing for the early identification of rifampicin resistance in Mali. Int J Tuberc Lung Dis 2021; 24:763-769. [PMID: 32912379 DOI: 10.5588/ijtld.19.0698] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND: Non-conversion on auramine smear microscopy indicates a lack of treatment response, possibly associated with initial rifampicin-resistant tuberculosis (RR-TB). However, dead bacteria still stain positive and may be detected. Fluorescein diacetate smear microscopy (FDA) shows live mycobacteria only. Therefore, we studied the potential of 2-month (2M) FDA for the identification of initial RR-TB.METHODS: Between 2015 and 2018, we enrolled new smear-positive pulmonary TB patients from five local centres in Bamako, Mali. After baseline screening, sputum samples were collected at 1M, 2M, 5M and 18M. We used rpoB sequencing to identify initial RR-TB.RESULTS: Of 1359 patients enrolled, 1019 (75%) had rpoB sequencing results. Twenty-six (2.6%, 95%CI: 1.7-3.7) had mutations conferring rifampicin resistance. Most frequent rpoB mutations were located at the codons Asp435Val (42.4%) and Ser450Leu (34.7%). Among patients with initial RR-TB, 72.2% were FDA-negative at 2M (P = 0.2). The positive and negative predictive value of 5M FDA for culture-based failure was respectively 20.0% and 94.7%.CONCLUSION: FDA did not identify the majority of patients with initial RR-TB or culture-based failure. As the full spectrum of mutations identified on sequencing was identified using Xpert, our data support its rapid universal implementation in Mali.
Collapse
Affiliation(s)
- B Diarra
- University Clinical Research Centre, SEREFO Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali, Unit of Mycobacteriology, Institute of Tropical Medicine Antwerp, Antwerp
| | - T Decroo
- Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Antwerp, Research Foundation Flanders, Brussels, Belgium
| | - A Somboro
- University Clinical Research Centre, SEREFO Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - G Coulibaly
- University Clinical Research Centre, SEREFO Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - M Tolofoudie
- University Clinical Research Centre, SEREFO Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - M Kone
- University Clinical Research Centre, SEREFO Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - B Degoga
- University Clinical Research Centre, SEREFO Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - F Diallo
- University Clinical Research Centre, SEREFO Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - A C G Togo
- University Clinical Research Centre, SEREFO Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - M Sanogo
- University Clinical Research Centre, SEREFO Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - Y S Sarro
- University Clinical Research Centre, SEREFO Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - A B Cisse
- Laboratoire National de Référence des Mycobactéries, Institut National de Recherche en Santé publique, Bamako, Mali
| | - O Kodio
- University Clinical Research Centre, SEREFO Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - B Baya
- University Clinical Research Centre, SEREFO Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - A Kone
- University Clinical Research Centre, SEREFO Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - M Maiga
- Global Health, Northwestern University, Chicago, IL, USA
| | - S Dao
- University Clinical Research Centre, SEREFO Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - I I Maiga
- Laboratoire d´analyses Médicales et Hygiène Hospitalière du Centre Hospitalier Universitaire du Point-G, Bamako, Mali
| | - R L Murphy
- Laboratoire National de Référence des Mycobactéries, Institut National de Recherche en Santé publique, Bamako, Mali
| | - S Siddiqui
- Collaborative Clinical Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
| | - Y Toloba
- Service de Pneumo-phtisiologie du Centre Hospitalier Universitaire du Point-G, Bamako
| | - B Konate
- Programme National de Lutte contre la Tuberculose (PNLT), Ministère de la santé et des Affaires Sociales, Bamako, Mali
| | - M Diakite
- University Clinical Research Centre, SEREFO Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - S Doumbia
- University Clinical Research Centre, SEREFO Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | | | - L Rigouts
- Unit of Mycobacteriology, Institute of Tropical Medicine Antwerp, Antwerp, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
| | - S Diallo
- University Clinical Research Centre, SEREFO Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - B C de Jong
- Unit of Mycobacteriology, Institute of Tropical Medicine Antwerp, Antwerp
| |
Collapse
|
9
|
Coulibaly N, Kone B, Sanogo M, G Togo AC, Diarra B, Sarro YS, Cisse AB, Kodio O, Coulibaly G, Kone M, Baya B, Maiga M, Dabitao D, Belson M, Dao S, Diallo S, Diakite M, Babana AH, Doumbia S. Performance of Mali's biosafety level 3 laboratory in the external quality assessment in preparedness of laboratory accreditation and support to clinical trials. Int J Mycobacteriol 2021; 9:29-33. [PMID: 32474485 PMCID: PMC8075184 DOI: 10.4103/ijmy.ijmy_5_20] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
Background: The external quality assessment (EQA) or external quality control is an evaluation conducted by a certified external organization to inquire about the quality of the results provided by a laboratory. The primary role of EQA is to verify the accuracy of laboratory results. This is essential in research because research data should be published in international peer-reviewed journals, and laboratory results must be repeatable. In 2007, the University Clinical Research Center (UCRC’s) biosafety level 3 (BSL-3) laboratory joined the EQA program with the College of American Pathologists in acid-fast staining and culture and identification of mycobacteria as per laboratory accreditation preparedness. Thus, after 11 years of participation, the goal of our study was to evaluate the performance of our laboratory during the different interlaboratory surveys. Methods: We conducted a descriptive retrospective study to evaluate the results of UCRC mycobacteriology laboratory from surveys conducted during 2007 and 2017. Results: Of the 22 evaluations, the laboratory had satisfactory (100% of concordance results) in 18 (81.8%) and good (80% of concordance results) in 4 (18.2%). Overall, the laboratory was above the commended/accepted limits of 75%. Conclusion: So far, UCRC’s BSL-3 performed well during the first 11 years of survey participation, and efforts should be deployed to maintain this high quality in the preparedness for laboratory accreditation and support to clinical trials.
Collapse
Affiliation(s)
- N Coulibaly
- University Clinical Research Center-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - B Kone
- University Clinical Research Center-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - M Sanogo
- University Clinical Research Center-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - A C G Togo
- University Clinical Research Center-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - B Diarra
- University Clinical Research Center-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - Y S Sarro
- University Clinical Research Center-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - A B Cisse
- National Referral Laboratory of Mycobacteriology, National Institute of Public Health, INSP, Bamako, Mali
| | - O Kodio
- University Clinical Research Center-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - G Coulibaly
- University Clinical Research Center-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - M Kone
- University Clinical Research Center-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - B Baya
- University Clinical Research Center-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - M Maiga
- University Clinical Research Center-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali; Center for Global Health, Northwestern University, Chicago, IL, USA
| | - D Dabitao
- University Clinical Research Center-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - M Belson
- Collaborative Clinical Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA
| | - S Dao
- University Clinical Research Center-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - S Diallo
- University Clinical Research Center-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - M Diakite
- University Clinical Research Center-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - A H Babana
- Microbiology and Biotechnology Research Laboratory, Faculty of Sciences and Techniques, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| | - S Doumbia
- University Clinical Research Center-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
| |
Collapse
|
10
|
Coulibaly K, Traoré S, Sanogo CO, Traoré L, Touré L, Tambassi SI, Keïta G, Diallo S, Traoré J, Diallo A. [Management of chronic osteomyilitis of limbs at kati teaching hospital]. Mali Med 2021; 36:32-35. [PMID: 37973601] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/19/2023]
Abstract
OBJECTIVES the purpose of this work was to describe the epidemiological, clinical, paraclinical and therapeutic aspect of surgical treatment of chronic osteomyilitis of limbs. PATIENTS METHODS it was a retrospective study over a period of 12 years, from January 2003 to December 2014. It covered all cases of chronic osteomyelitis osteonecrosis treated our service. RESULTS The authors report the results of the surgical treatment of a series 56 patients operated on for chronic limb osteomyelitis. The mean age was 20.7 years with extremes of 6 months and 56 years. The tibia and femur were the most affected segments. Staphylococcus aureus was the most frequently found germ, 80% of the cases. We obtained complete healing with total cure in 68% of cases and recurrence of suppuration in 32% of cases. CONCLUSION Chronic osteomyelitis of limbs is a frequent pathology in Africa. Staphylococcus aureus was the most frequently found germ. Surgery in a time seems a good alternative. The rate of recurrence of the suppuration remains high.
Collapse
Affiliation(s)
- K Coulibaly
- Service d'orthopédie traumatologie du CHU de Kati. Koulikoro-Mali
| | - S Traoré
- Service d'orthopédie traumatologie du CHU de Kati. Koulikoro-Mali
| | - C O Sanogo
- Service d'orthopédie traumatologie du CHU de Kati. Koulikoro-Mali
| | - L Traoré
- CHU Mère-Enfant le Luxembourg de Bamako-Mali
| | | | - S I Tambassi
- Service d'orthopédie traumatologie du CHU de Kati. Koulikoro-Mali
| | - G Keïta
- Service d'orthopédie traumatologie du CHU de Kati. Koulikoro-Mali
| | - S Diallo
- Service d'orthopédie traumatologie du CHU de Kati. Koulikoro-Mali
| | - J Traoré
- Service d'orthopédie traumatologie du CHU de Kati. Koulikoro-Mali
| | - A Diallo
- Service d'orthopédie traumatologie du CHU de Kati. Koulikoro-Mali
| |
Collapse
|
11
|
Bonnaire A, Vernet-Garnier V, Lebrun D, Bajolet O, Bonnet M, Ohl X, Diallo S, Bani-Sadr F. Efficacité de la clindamycine en bithérapie dans les infections ostéoarticulaires à staphylocoque résistant à l’érythromycine et sensible à la clindamycine. Med Mal Infect 2020. [DOI: 10.1016/j.medmal.2020.06.273] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
12
|
Dièye A, Diop Dia A, Niang S, Diallo S, Dia D, Diédhiou M, Seck B, Lo S, Dia-Badiane N. Connaissances, attitudes et pratiques des détenus sur la tuberculose. Med Mal Infect 2020. [DOI: 10.1016/j.medmal.2020.06.325] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
13
|
Gerbaux M, Diallo S, Dedeken L, Dangoisse C, Bott A, Heritier S, Salik D, Ferster A. Effective rescue treatment with vemurafenib of an infant with high-risk Langerhans cell histiocytosis. Ann Dermatol Venereol 2020; 147:782-785. [PMID: 32653217 DOI: 10.1016/j.annder.2020.05.005] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2019] [Revised: 02/19/2020] [Accepted: 05/05/2020] [Indexed: 11/19/2022]
Abstract
INTRODUCTION The recently identified role of a BRAF somatic mutation in the pathophysiology of Langerhans cell histiocytosis (LCH) offers new therapeutic options. Herein we describe the case of a 10-month-old infant with refractory high-risk LCH successfully treated with vemurafenib. OBSERVATION The patient first presented with cutaneous LCH at the age of 2 months. The disease remained undiagnosed until she was 6 months old, when it rapidly evolved to a multisystemic high-risk and life-threatening disease, refractory to 2 lines of chemotherapy. BRAFV600E mutation was found at skin biopsy, and targeted therapy with vemurafenib was started when she was 10 months old. The treatment induced a fast and sustained response, but rapid relapse occurred after treatment discontinuation, leading to resumption of treatment, once more resulting in a sustained response. CONCLUSION Our case highlights the first-line role of dermatologists in establishing the diagnosis of LCH, especially in children, in whom the eruption may be difficult to identify, leading to delayed diagnosis. Targeted therapy with vemurafenib has recently been described in children in this indication and our results support its efficacy, highlighting the need for prolonged treatment and raising the question of maintenance therapy, as well as the necessity for large-scale and long-term studies.
Collapse
Affiliation(s)
- M Gerbaux
- Department of hematology and oncology, université libre de Bruxelles, hôpital universitaire des enfants reine Fabiola, 266, avenue Brugmann, 1180 Uccle, Brussels, Belgium.
| | - S Diallo
- Department of hematology and oncology, université libre de Bruxelles, hôpital universitaire des enfants reine Fabiola, 266, avenue Brugmann, 1180 Uccle, Brussels, Belgium
| | - L Dedeken
- Department of hematology and oncology, université libre de Bruxelles, hôpital universitaire des enfants reine Fabiola, 266, avenue Brugmann, 1180 Uccle, Brussels, Belgium
| | - C Dangoisse
- Department of dermatology, université libre de Bruxelles, hôpital universitaire des enfants reine Fabiola, Brussels, Belgium
| | - A Bott
- Department of dermatology, université libre de Bruxelles, hôpital universitaire des enfants reine Fabiola, Brussels, Belgium
| | - S Heritier
- JF. Emile, laboratory EA4340, GHU Paris-Saclay, Versailles university, Ambroise-Paré hospital, Paris, France
| | - D Salik
- Department of dermatology, université libre de Bruxelles, hôpital universitaire des enfants reine Fabiola, Brussels, Belgium
| | - A Ferster
- Department of hematology and oncology, université libre de Bruxelles, hôpital universitaire des enfants reine Fabiola, 266, avenue Brugmann, 1180 Uccle, Brussels, Belgium
| |
Collapse
|
14
|
Kaboré B, Post A, Lompo P, Bognini JD, Diallo S, Kam BTD, Rahamat-Langendoen J, Wertheim HFL, van Opzeeland F, Langereis JD, de Jonge MI, Tinto H, Jacobs J, van der Ven AJ, de Mast Q. Aetiology of acute febrile illness in children in a high malaria transmission area in West Africa. Clin Microbiol Infect 2020; 27:590-596. [PMID: 32505586 DOI: 10.1016/j.cmi.2020.05.029] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2020] [Revised: 05/19/2020] [Accepted: 05/25/2020] [Indexed: 01/12/2023]
Abstract
OBJECTIVES Areas with declining malaria transmission in sub-Saharan Africa have recently witnessed important changes in the aetiology of childhood acute febrile illness (AFI). We describe the aetiology of AFI in a high malaria transmission area in rural Burkina Faso. METHODS In a prospective hospital-based diagnostic study, children aged 3 months to 15 years with AFI were recruited and assessed using a systematic diagnostic protocol, including blood cultures, whole blood PCR on a selection of bacterial pathogens, malaria diagnostics and a multiplex PCR on nasopharyngeal swabs targeting 21 viral and 4 bacterial respiratory pathogens. RESULTS A total of 589 children with AFI were enrolled from whom an infectious disease was considered in 575 cases. Acute respiratory tract infections, malaria and invasive bacterial infections (IBI) accounted for 179 (31.1%), 175 (30.4%) and 75 (13%) of AFI cases respectively; 16 (21.3%) of IBI cases also had malarial parasitaemia. A viral pathogen was demonstrated from the nasopharynx in 157 children (90.7%) with respiratory tract symptoms. Of all children with viral respiratory tract infections, 154 (92.4% received antibiotics, whereas no antibiotic was provided in 13 (17%) of IBI cases. CONCLUSIONS Viral respiratory infections are a common cause of childhood AFI in high malaria transmission areas, next to malaria and IBI. These findings highlight the importance of interventions to improve targeted treatment with antimicrobials. Most patients with viral infections received antibiotics unnecessarily, while a considerable number with IBI did not receive antibiotics.
Collapse
Affiliation(s)
- B Kaboré
- Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands; IRSS/Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso
| | - A Post
- Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands
| | - P Lompo
- IRSS/Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso
| | - J D Bognini
- IRSS/Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso
| | - S Diallo
- IRSS/Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso
| | - B T D Kam
- IRSS/Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso
| | - J Rahamat-Langendoen
- Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands; Radboudumc Center for Infectious Diseases (RCI), the Netherlands
| | - H F L Wertheim
- Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands; Radboudumc Center for Infectious Diseases (RCI), the Netherlands
| | - F van Opzeeland
- Section of Paediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands
| | - J D Langereis
- Radboudumc Center for Infectious Diseases (RCI), the Netherlands; Section of Paediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands
| | - M I de Jonge
- Radboudumc Center for Infectious Diseases (RCI), the Netherlands; Section of Paediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands
| | - H Tinto
- IRSS/Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso; Centre Muraz, Bobo-Dioulasso, Burkina Faso
| | - J Jacobs
- Department of Clinical Sciences, Institute of Tropical Medicine (ITM), Antwerp, Belgium; Department of Microbiology, Immunology and Transplantation, University of Leuven (KU Leuven), Leuven, Belgium
| | - A J van der Ven
- Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands; Radboudumc Center for Infectious Diseases (RCI), the Netherlands
| | - Q de Mast
- Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands; Radboudumc Center for Infectious Diseases (RCI), the Netherlands.
| |
Collapse
|
15
|
Julien G, Francois M, Vernet-Garnier V, Bajolet O, Lebrun D, Hentzien M, Ohl X, Diallo S, Bani-Sadr F. Short duration of post-amputation antibiotic therapy in diabetic foot patients with total resection of osteomyelitis. Med Mal Infect 2020; 50:433-435. [PMID: 32360115 DOI: 10.1016/j.medmal.2020.04.015] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2019] [Revised: 01/07/2020] [Accepted: 04/17/2020] [Indexed: 11/17/2022]
Abstract
BACKGROUND Short duration of post-amputation antibiotic therapy (2-5 days) is recommended in patients with diabetic foot osteomyelitis after total resection of infected bone tissue. OBJECTIVE To evaluate the long-term effectiveness of short-duration post-amputation antibiotic therapy in diabetic patients with total resection of osteomyelitis assessed by sterile bone bacteriological samples obtained from the resection margin. METHODS The endpoint was the absence of osteomyelitis relapse at 6 months, defined as recurrence of osteomyelitis with the need for surgical revision and/or new bone antibiotic therapy. RESULTS Among 15 patients included, 12 (80%) were cured without recurrence of osteomyelitis at 6 months, with a mean duration of antibiotic therapy of 8.3±5.9 days post surgery. This result is comparable to literature data, while all of them reported longer duration of antibiotic therapy and/or shorter follow-up. CONCLUSION Short duration of post-amputation antibiotic therapy in diabetic patients with sterile bacteriological samples obtained from resection margin seems effective.
Collapse
Affiliation(s)
- G Julien
- Department of internal medicine and infectious diseases, Reims teaching hospitals, Reims, France
| | - M Francois
- Department of endocrinology-diabetology, Reims teaching hospitals, Reims, France
| | - V Vernet-Garnier
- Department of bacteriology, Reims teaching hospitals, Reims, France
| | - O Bajolet
- Department of hygiene, Reims teaching hospitals, Reims, France
| | - D Lebrun
- Department of internal medicine and infectious diseases, Manchester hospital, Charleville-Mezieres, France
| | - M Hentzien
- Department of internal medicine and infectious diseases, Reims teaching hospitals, Reims, France
| | - X Ohl
- Department of orthopedic surgery, Reims teaching hospitals, Reims, France
| | - S Diallo
- Department of orthopedic surgery, Reims teaching hospitals, Reims, France
| | - F Bani-Sadr
- Department of internal medicine and infectious diseases, Reims teaching hospitals, Reims, France.
| |
Collapse
|
16
|
Traoré S, Coulibaly K, Kéita G, Dakouo R, Traoré T, Tambassi S, Diallo S. [Aseptic nonunion of patella at the Centre Hospitalier Universitaire Bocar Sidy Sall de Kati about 25 cases]. Mali Med 2020; 35:23-27. [PMID: 37978737] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/19/2023]
Abstract
OBJECTIVE The objective of Our study was to describe the epidemiological, clinical, therapeutic and prognostic aspects of Nonunion of patella fractures. PATIENTS METHODS It was a retrospective study done concerning 25 patients treated fromJanuary 2005 to December 2015 in the orthopedic trauma service CHU Bocar Sidy SALL Kati. RESULTS We gather together 25 cases of Nonunion of patella fractures disease among 28 caseswhich was about 89.28%. Our patients were divided into 20 men and 5 women, mean age was 36 years, ranging from ages 22 to 75 years. Posttraumatic period was 6-18 months. The initial fracture was neglected in 21 cases and treated in 4 cases. Physical examination revealed lameness in 92% of cases, atrophy of the quadriceps in 56% of cases, joint stiffness, 56% and an inter-fragmentary gap in 92% of patients. The radiographic data were consistent with pseudoarthrosis in all cases. The inter-fragmentary gap was 36 mm on average. The care of our patients was based on plugging and guy-wiring in 64 % of cases and strapping pre- and peri patella in 12% of cases. A partial patellectomy was practiced in 2 cases. A VY plasty of the quadriceps was recommended in 4 cases.The patients were reviewed after a mean of 10 months (8 months- 24 months). Functional outcomes analyzed using Bostman scores were excellent in 4 cases (16%), good in 18 cases (72%) and poor in 3 cases (12%). CONCLUSION Nonunion of the patella is mostly due to the lack of treatment or wrong treatment leads. Treatment with plugging and guy-wiring seems the most appropriate method.
Collapse
Affiliation(s)
- S Traoré
- Service d'orthopédie traumatologie du CHU Bocar Sidy SALL de Kati, BP 16, tél : 00223-21-27-20-65 Bamako-Mali
| | - K Coulibaly
- Service d'orthopédie traumatologie du CHU Bocar Sidy SALL de Kati, BP 16, tél : 00223-21-27-20-65 Bamako-Mali
| | - G Kéita
- Service d'orthopédie traumatologie du CHU Bocar Sidy SALL de Kati, BP 16, tél : 00223-21-27-20-65 Bamako-Mali
| | - R Dakouo
- Service d'orthopédie traumatologie du CHU Bocar Sidy SALL de Kati, BP 16, tél : 00223-21-27-20-65 Bamako-Mali
| | - T Traoré
- Service d'orthopédie traumatologie du CHU Bocar Sidy SALL de Kati, BP 16, tél : 00223-21-27-20-65 Bamako-Mali
| | - Si Tambassi
- Service d'orthopédie traumatologie du CHU Bocar Sidy SALL de Kati, BP 16, tél : 00223-21-27-20-65 Bamako-Mali
| | - S Diallo
- Service d'orthopédie traumatologie du CHU Bocar Sidy SALL de Kati, BP 16, tél : 00223-21-27-20-65 Bamako-Mali
| |
Collapse
|
17
|
Diarra B, Tolofoudie M, Sarro YS, Togo ACG, Bane S, Nientao I, Cisse AB, Kone M, Somboro A, Degoga B, Diallo F, Coulibaly G, Kodio O, Sanogo M, Kone B, Diabate S, Baya B, Kone A, Dabitao D, Maiga M, Belson M, Dao S, Maiga II, Murphy RL, Siddiqui S, Toloba Y, Konate B, Doumbia S, de Jong BC, Diallo S. Diabetes Mellitus among new tuberculosis patients in Bamako, Mali. J Clin Tuberc Other Mycobact Dis 2019; 17:100128. [PMID: 31788570 PMCID: PMC6879999 DOI: 10.1016/j.jctube.2019.100128] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/02/2022] Open
Abstract
Introduction Diabetes Mellitus (DM) increases worldwide, mostly in low- and middle-income countries. In Mali, the prevalence in the adult population is estimated at 1.8%, but tuberculosis (TB) patients are not systematically screened. The goal of our study was to determine the prevalence of DM among newly diagnosed TB patients. Methods We conducted a cross sectional study and a pilot prospective cohort study in four health centers in Bamako. All patients underwent fasting capillary-blood glucose (FCBG) test at Day 0, and repeated after one-week of TB treatment. Venous FBG test was performed for discrepancies between the two FCBG results. Thereafter, FCBG was performed for pilot study at month-2 (M2) and M5 of TB treatment. Results Two hundred and one patients were enrolled in this study. Impaired fasting blood glucose was identified in 17 (8.5%), of whom 11 (5.5%) had DM (VFBG >7 mmol/L). Among patients with DM, seven (63.6%) had successful TB treatment outcome, versus 142 (74.7%) of those without DM (p = 0.64), and (OR: 1.69, 95%CI 0.47–6.02). Conclusion The prevalence of DM among TB patients in Bamako exceeds that of the general population and screening at TB diagnosis suffices to identify those with DM. Systematic screening of both diseases will allow better treatment.
Collapse
Affiliation(s)
- B Diarra
- University Clinical Research Center (UCRC)-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.,Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium
| | - M Tolofoudie
- University Clinical Research Center (UCRC)-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - Y S Sarro
- University Clinical Research Center (UCRC)-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - A C G Togo
- University Clinical Research Center (UCRC)-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - S Bane
- University Clinical Research Center (UCRC)-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - I Nientao
- Service de Médecine et d'Endocrinologie de l'hôpital du Mali, Bamako, Mali
| | - A B Cisse
- Laboratoire National de Référence des Mycobactéries (LNR), Institut National de Recherche en Santé publique (INRSP), Bamako, Mali
| | - M Kone
- University Clinical Research Center (UCRC)-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - A Somboro
- University Clinical Research Center (UCRC)-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - B Degoga
- University Clinical Research Center (UCRC)-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - F Diallo
- University Clinical Research Center (UCRC)-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - G Coulibaly
- University Clinical Research Center (UCRC)-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - O Kodio
- University Clinical Research Center (UCRC)-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - M Sanogo
- University Clinical Research Center (UCRC)-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - B Kone
- University Clinical Research Center (UCRC)-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - S Diabate
- University Clinical Research Center (UCRC)-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - B Baya
- University Clinical Research Center (UCRC)-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - A Kone
- University Clinical Research Center (UCRC)-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - D Dabitao
- University Clinical Research Center (UCRC)-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - M Maiga
- Global Health, Northwestern University, Chicago, IL, United States
| | - M Belson
- Collaborative Clinical Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States
| | - S Dao
- University Clinical Research Center (UCRC)-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - I I Maiga
- Laboratoire d'analyses Médicales et Hygiène Hospitalière du Centre Hospitalier Universitaire du Point-G, Bamako, Mali
| | - R L Murphy
- Global Health, Northwestern University, Chicago, IL, United States
| | - S Siddiqui
- Collaborative Clinical Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States
| | - Y Toloba
- Service de Pneumo-phtisiologie du Centre Hospitalier Universitaire du Point-G, Bamako, Mali
| | - B Konate
- Programme National de Lutte contre la Tuberculose (PNLT), Ministère de la santé et de l'hygiène publique, Bamako, Mali
| | - S Doumbia
- University Clinical Research Center (UCRC)-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - B C de Jong
- Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium
| | - S Diallo
- University Clinical Research Center (UCRC)-SEREFO-Laboratory, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| |
Collapse
|
18
|
Roberts SA, Brabin L, Diallo S, Gies S, Nelson A, Stewart C, Swinkels DW, Geurts-Moespot AJ, Kazienga A, Ouedraogo S, D'Alessandro U, Tinto H, Brabin BJ. Mucosal lactoferrin response to genital tract infections is associated with iron and nutritional biomarkers in young Burkinabé women. Eur J Clin Nutr 2019; 73:1464-1472. [PMID: 31168085 PMCID: PMC6842079 DOI: 10.1038/s41430-019-0444-7] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2019] [Revised: 04/29/2019] [Accepted: 05/19/2019] [Indexed: 12/14/2022]
Abstract
BACKGROUND/OBJECTIVES The iron-binding affinity of vaginal lactoferrin (Lf) reduces iron available to genital pathogens. We describe host reproductive, nutritional, infection and iron biomarker profiles affecting vaginal Lf concentration in young nulliparous and primigravid women in Burkina Faso. SUBJECTS/METHODS Vaginal eluates from women who had participated in a randomized, controlled periconceptional iron supplementation trial were used to measure Lf using a competitive double-sandwich ELISA. For this analysis samples from both trial arms were combined and pregnant and non-pregnant cohorts compared. Following randomization Lf was measured after 18 months (end assessment) for women remaining non-pregnant, and at two antenatal visits for those becoming pregnant. Associations between log Lf levels and demographic, anthropometric, infection and iron biomarker variables were assessed using linear mixed models. RESULTS Lf samples were available for 712 non-pregnant women at end assessment and for 303 women seen at an antenatal visit. Lf concentrations of pregnant women were comparable to those of non-pregnant, sexually active women. Lf concentration increased with mid-upper-arm circumference, (P = 0.047), body mass index (P = 0.018), Trichomonas vaginalis (P < 0.001) infection, bacterial vaginosis (P < 0.001), serum C-reactive protein (P = 0.048) and microbiota community state types III/IV. Adjusted Lf concentration was positively associated with serum hepcidin (P = 0.047), serum ferritin (P = 0.018) and total body iron stores (P = 0.042). There was evidence that some women maintained persistently high or low Lf concentrations from before, and through, pregnancy. CONCLUSION Lf concentrations increased with genital infection, higher BMI, MUAC, body iron stores and hepcidin, suggesting nutritional and iron status influence homeostatic mechanisms controlling vaginal Lf responses.
Collapse
Affiliation(s)
- S A Roberts
- Centre for Biostatistics, Division of Population Health, Health Services Research and Primary Care, Faculty of Biology, Medicine and Health, School of Medical Sciences, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
| | - L Brabin
- Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
| | - S Diallo
- Clinical Research Unit of Nanoro (URCN/IRSS), Nanoro, Burkina Faso
| | - S Gies
- Department of Biomedical Sciences, Prince Leopold Institute of Tropical Medicine, Antwerp, Belgium and Medical Mission Institute, Würzburg, Germany
| | - A Nelson
- Faculty of Health and Life Sciences, University of Northumbria, Northumberland Building, Newcastle-upon-Tyne, UK
| | - C Stewart
- Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA
| | - D W Swinkels
- Department of Laboratory Medicine (TLM 830), Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.,Hepcidinanalysis.com., Nijmegen, The Netherlands
| | - A J Geurts-Moespot
- Department of Laboratory Medicine (TLM 830), Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
| | - A Kazienga
- Clinical Research Unit of Nanoro (URCN/IRSS), Nanoro, Burkina Faso
| | - S Ouedraogo
- Clinical Research Unit of Nanoro (URCN/IRSS), Nanoro, Burkina Faso
| | - U D'Alessandro
- Medical Research Council Unit (MRC), Fajara, The Gambia.,London School of Hygiene and Tropical Medicine, London, UK
| | - H Tinto
- Clinical Research Unit of Nanoro (URCN/IRSS), Nanoro, Burkina Faso
| | - B J Brabin
- Liverpool School of Tropical Medicine, and Institute of Infection and Global Health, University of Liverpool, Liverpool, UK. .,Global Child Health Group, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
| |
Collapse
|
19
|
Condé K, Niasse M, Garba MS, Diouf C, Diallo S. Late-onset spondyloarthritis: a study of 133 patients in Dakar, Senegal. Med Sante Trop 2019; 29:220-221. [PMID: 31379352 DOI: 10.1684/mst.2019.0903] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
Reports of late-onset spondyloarthritis in sub-Saharan Africa are sparse. This series allows us to describe the characteristics of this disease in Senegal. This is a retrospective study conducted in the Rheumatology Department of the Dantec University Hospital (Dakar) where we reviewed records of spondyloarthritis cases. Its diagnosis met the modified ASAS and New York criteria. Late-onset was defined as after the age of 55 years. During the study period, the department managed 133 late-onset patients, or 38% of all spondyloarthritis cases (350). Age ranged from 65 to 74 years, with a mean of 66. HLA B 27 phenotyping was performed in 89 patients; 39 patients were HLA B27 positive (29%). The treatments were based on DMARDs (salazopyrin and methotrexate).
Collapse
Affiliation(s)
- K Condé
- Service de rhumatologie, CHU Ignace-Deen, Université Gamal Abdel Nasser de Conakry, Guinée
| | - M Niasse
- Service de rhumatologie, CHU Aristide Le Dantec, Université Cheick Anta Diop de Dakar, Sénégal
| | - M S Garba
- Service de rhumatologie, Centre hospitalier régional de Maradi, Université de Maradi, Niger
| | - C Diouf
- Service de rhumatologie, CHU Aristide Le Dantec, Université Cheick Anta Diop de Dakar, Sénégal
| | - S Diallo
- Service de rhumatologie, CHU Aristide Le Dantec, Université Cheick Anta Diop de Dakar, Sénégal
| |
Collapse
|
20
|
Coulibaly M, Traoré D, Togola B, Sanogo S, Bengaly B, Kanté A, Ouattara D, Coulibaly B, Ba B, Diallo S, Ongoiba N. [Diagnosis and treatment of acute surgical abdomen in Koutiala]. Mali Med 2019; 34:11-14. [PMID: 35897200] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
PURPOSE To describe the epidemiological, clinical and therapeutic aspects of acute surgical abdomens at the Koutiala Reference Health Center. PATIENTS AND METHOD This was a prospective and descriptive study from August 1, 2017 to May 31, 2018. It included all patients operated on for acute abdomen in the General Surgery Department of the Koutiala Reference Health Center. The study did not include the nonoperated surgical acute abdomens, the non-surgical acute abdomens. Clavien-Dindo classification was used to evaluate complications. RESULTS One hundred patients were registered. Acute surgical abdomens accounted for 8.4% of consultations (n = 1190), 27.7% of surgical procedures (n = 361) and 70% of surgical emergencies (n = 142). The average age was 34.4 years ± 18.5. Men were in the majority with 70%. The mean duration of change in symptomatology was 4.8 days ± 5.4. Patients consulted for abdominal pain (100%), fever (60%), vomiting (88%) and discontinuation of materials and gases (32%). The physical examination noted abdominal distension (53%), abdominal contracture (36%), abdominal defense (56%) and pain in the cul de sac of Douglas (95%). X-rays of the abdomen without preparation and abdominopelvic ultrasonography contributed to the diagnosis in 46% of cases and 18% of cases, respectively. Acute appendicitis (35%) was the most common etiology followed by acute peritonitis (31%) and acute intestinal obstruction (15%). We performed an appendectomy in 45 patients (45%), resection anastomosis (15%) and excision-suture (13%). The average duration of hospitalization was 4.7 days. The morbidity was 12%. According to the Clavien-Dindo classification, 9 patients were grade III and 3 grade V. The mortality was 3%. CONCLUSION Acute surgical abdomens are the most common emergencies in our practice. The diagnosis is clinical and para-clinical most often. Morbidity and mortality remain elevated. The outcome of treatment depends on early management and mastery of abdominal surgery techniques.
Collapse
Affiliation(s)
| | - D Traoré
- Faculté de médecine de l'USTTB, Bamako, MALI
- Chirurgie B, CHU Point G, Bamako, MALI
| | - B Togola
- Faculté de médecine de l'USTTB, Bamako, MALI
- Chirurgie B, CHU Point G, Bamako, MALI
| | - S Sanogo
- Chirurgie B, CHU Point G, Bamako, MALI
| | - B Bengaly
- Faculté de médecine de l'USTTB, Bamako, MALI
- Chirurgie B, CHU Point G, Bamako, MALI
| | - A Kanté
- Faculté de médecine de l'USTTB, Bamako, MALI
- Chirurgie B, CHU Point G, Bamako, MALI
| | | | - B Coulibaly
- Faculté de médecine de l'USTTB, Bamako, MALI
- Chirurgie B, CHU Point G, Bamako, MALI
| | - Babou Ba
- Faculté de médecine de l'USTTB, Bamako, MALI
- Chirurgie B, CHU Point G, Bamako, MALI
| | - S Diallo
- Chirurgie B, CHU Point G, Bamako, MALI
| | - N Ongoiba
- Faculté de médecine de l'USTTB, Bamako, MALI
- Chirurgie B, CHU Point G, Bamako, MALI
| |
Collapse
|
21
|
Diallo SH, Kone M, Sogoba Y, Tanoh AC, Cissoko Y, Diallo S, Traoré Z, Saliou M, Camara M, Kayentao K, Maiga Y. [Impact of migraine on life quality in school environment in Bamako, Mali]. Mali Med 2019; 34:30-33. [PMID: 35897212] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
INTRODUCTION Migraine is a disabiliting disease accounting for 3%. Its prevalence and impact on the schoolar population deserves to be known. METHODOLOGY This is a five-month cross-sectional and descriptive study of students under 23 years of age at the high school in Bamako, Mali. The sampling was exhaustive and the population was stratified into school classes. Data related to the impact and disability of migraine were collected from a survey sheet integrating internationally validated items (GRIM, MIDAS, Headache Impact Test). RESULTS The prevalence of migraine was 21.0%. The sex ratio was 0.58. The average age was 17 years. Headache was pulsatile in 88.3% of cases, exacerbated by physical activities in 5.4%, unilateral topography in 73.2% of students. Phonophobia, photophobia were the most described signs of accompaniment. The intensity of pain was between 9 -10 in 69.5%. School absenteeism was ranged from 1 to 14 days in 91.2% of cases. CONCLUSION Migraine is a real public health concern in schools in Bamako because of its prevalence and its impact on academic performance.
Collapse
Affiliation(s)
- S H Diallo
- Service de Neurologie Centre Hospitalo Universitaire Gabriel Touré
| | - M Kone
- Service de Neurologie Centre Hospitalo Universitaire Gabriel Touré
| | - Y Sogoba
- Service de Neurochirurgie CHU Gabriel Touré
| | - A C Tanoh
- Service de Neurologie CHU Cocody, UFR des Sciences médicales, Abidjan RCI
| | - Y Cissoko
- Service de Maladies infectieuses Centre Hospitalo Universitaire Point G
| | - S Diallo
- Service de Neurologie Centre Hospitalo Universitaire Gabriel Touré
| | - Z Traoré
- Service de Neurologie Centre Hospitalo Universitaire Gabriel Touré
| | - M Saliou
- Service de Médecine Interne et de Diabétologie CHU Gabriel Touré
| | - M Camara
- Service de Neurologie Centre Hospitalo Universitaire Gabriel Touré
| | | | - Y Maiga
- Service de Neurologie Centre Hospitalo Universitaire Gabriel Touré
| |
Collapse
|
22
|
Coulibaly M, Traoré D, Togola B, Sanogo S, Bengaly B, Kanté A, Ouattara D, Coulibaly B, Ba B, Diallo S, Ongoiba N. [Non-traumatic digestive perforation in Koutiala: epidemiological and therapeutic aspects]. Mali Med 2019; 34:20-23. [PMID: 35897222] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
PURPOSE the aim of this study was to evaluate the clinical and therapeutic aspects of non-traumatic digestive perforations at the Koutiala Reference Health Center. PATIENTS AND METHODS This was a prospective and descriptive study from August 1, 2017 to December 31, 2018. Patients admitted and operated on for non-traumatic digestive perforation were included. The parameters studied were age, sex, frequency, clinical aspects, etiologies, treatment and operative follow-up. RESULT Sixty-one patients were registered. Non-traumatic digestive perforations accounted for 78.2% of cases of acute peritonitis (n = 78). Men were in the majority with 73.8%. The average age was 34.5 years old. The symptomatology was represented by abdominal pain in all patients, vomiting in 56 patients and fever in 42 patients. The mean duration of evolution of the symptomatology was 5.5 days. On physical examination, the most common signs were abdominal contracture with 81.9%, disappearance of prehepatic maturation (52.4%) and pain in rectal examination (95.1%). Radiological pneumoperitoneum was found in 39 patients. The serodiagnosis of Widal was positive in 15 cases. The etiologies were dominated by perforation of infectious origin with 77.0% (46). The perforation was ileal in 28 patients, appendicular in 18 patients and gastroduodenal in 11 patients. Excision-suturing of the perforation was done in 30 patients, resection anastomosis in 8 patients and appendectomy in 18 patients. Morbidity and mortality were respectively 14.7% and 6.5%. CONCLUSION Non-traumatic digestive perforations are the first cause of peritonitis in our department. The ileal seat is the most common and is most often secondary to typhoid fever. Morbidity and mortality remain high and this result is a reflection of late diagnosis which is the main factor of severity of digestive perforations.
Collapse
Affiliation(s)
| | - D Traoré
- Faculté de médecine de l'USTTB, Bamako, MALI
- Chirurgie B, CHU Point G, Bamako, MALI
| | - B Togola
- Faculté de médecine de l'USTTB, Bamako, MALI
- Chirurgie B, CHU Point G, Bamako, MALI
| | - S Sanogo
- Chirurgie B, CHU Point G, Bamako, MALI
| | - B Bengaly
- Faculté de médecine de l'USTTB, Bamako, MALI
- Chirurgie B, CHU Point G, Bamako, MALI
| | - A Kanté
- Faculté de médecine de l'USTTB, Bamako, MALI
- Chirurgie B, CHU Point G, Bamako, MALI
| | | | - B Coulibaly
- Faculté de médecine de l'USTTB, Bamako, MALI
- Chirurgie B, CHU Point G, Bamako, MALI
| | - Babou Ba
- Faculté de médecine de l'USTTB, Bamako, MALI
- Chirurgie B, CHU Point G, Bamako, MALI
| | - S Diallo
- Chirurgie B, CHU Point G, Bamako, MALI
| | - N Ongoiba
- Faculté de médecine de l'USTTB, Bamako, MALI
- Chirurgie B, CHU Point G, Bamako, MALI
| |
Collapse
|
23
|
Agaly H, Koné FI, Djerma I, Diallo S, Camara I, Kanikomo D, Diallo O, Samaké B, Sogoba Y, Sogoba B. [Clinical and prognostic epidemiological study of extra-dural hematomas performed in the neurosurgery department of the CHU Gabriel Touré about 112 cases]. Mali Med 2019; 34:23-27. [PMID: 35897202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
UNLABELLED Extra Dural hematoma is a fairly common complication in traumatic cranial patients whose prognosis depends on early and appropriate management. PURPOSE To carry out an epidemiological, clinical and therapeutic study of extradural haematomas operated in department. METHOD A retrospective and descriptive study carried out in the neurosurgery department of the Gabriel Toure hospital spread over a period of 5 years. All records of the patients who underwent extra-dural hematoma surgery were stripped, for a total of 112. Data related to socio-professional, clinical and therapeutic characteristics were studied. RESULTS The mean age was 24.47 years with extremes ranging from 3 to 53 years old. The ratio was 9.2 in favor of the man. Road accidents are more frequent with 66.1%. The free interval was founding 68.2%. At admission, 5.4% of patients shad a glascow scale of less than 8, anisocoriain 33.1% and contralateral motor deficit 43%. CT allowed the early diagnosis of 100% extra dural hematoma. 42.9% of patients were operated on before the first 8 hours. Mortality was 4.4%. CONCLUSION Extra duralhematomais a neurosurgical emergency with good prognosis if management isearly and appropriate.
Collapse
Affiliation(s)
- H Agaly
- Service de neurochirurgie CHU Gabriel TOURE
| | - F I Koné
- Service de neurologie CHU Gabriel TOURE
| | | | - S Diallo
- Service d'anesthésie et de réanimation CHU Gabriel TOURE
| | - I Camara
- Service de neurochirurgie Hôpital du Mali
| | | | | | | | | | | |
Collapse
|
24
|
Senghore M, Diarra B, Gehre F, Otu J, Worwui A, Muhammad A, Sanogo M, Baya B, Orsega S, Doumbia S, Diallo S, de Jong B, Pallen M, Antonio M. Evolution of virulent genotypes and an emerging threat of multidrug resistant tuberculosis in Bamako, Mali. Int J Infect Dis 2018. [DOI: 10.1016/j.ijid.2018.04.3573] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
|
25
|
Toloba Y, Ouattara K, Soumaré D, Kanouté T, Berthé G, Baya B, Konaté B, Keita M, Diarra B, Cissé A, Camara FS, Diallo S. [Multidrug-resistant tuberculosis (MDR-TB) in a black African carceral area: Experience of Mali]. Rev Pneumol Clin 2018; 74:22-27. [PMID: 29246463 DOI: 10.1016/j.pneumo.2017.10.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/08/2017] [Revised: 08/04/2017] [Accepted: 10/30/2017] [Indexed: 06/07/2023]
Abstract
INTRODUCTION Prison constitutes a risk factor for the emergence of multi-drug resistance of tuberculosis (MDR-TB). The aim of this work was to study MDR-TB in a black African carceral center. MATERIAL AND METHODS Prospective study from January to December 2016 at the central house of arrest for men, Bamako. The study population was composed of tuberculous detainee. The suspicion of MDR-TB was done in any tuberculosis case remained positive in the second month of first-line treatment or in contact with an MDR-TB case. RESULT Among 1622 detainee, 21 cases of pulmonary tuberculosis were notified (1.29%), with an annual incidence of 13 cases/1000 detainee, they were 16 cases of SP-PTB (microscopy smear positive tuberculosis) and five cases of microscopy smear negative tuberculosis. The mean age was 28±7 years, extremes of 18 and 46 years. A negative association was found between the notion of smoking and occupation in the occurrence of tuberculosis (OR=0.036, [95% CI: 0.03-0.04], P=0.03. Among the 21 tuberculosis cases notified, one confirmed case of MDR-TB was detected (4.7%). In the first semester of 2016 cohort, we notified a cure rate of 87.5% (7/8 SP-PTB cases), and the confirmed MDR-TB case on treatment (21-month regimen), evolution enameled of pulmonary and hearing sequelae at seven months treatment. CONCLUSION It was the first case of MDR-TB detected in a prison in Mali. Late diagnosis, evolution is enameled of sequelae and side effects.
Collapse
Affiliation(s)
- Y Toloba
- Service de pneumologie, CHU du Point-G, E1631 Bamako, Mali.
| | - K Ouattara
- Service de pneumologie, CHU du Point-G, E1631 Bamako, Mali
| | - D Soumaré
- Service de pneumologie, CHU du Point-G, E1631 Bamako, Mali
| | - T Kanouté
- Service de pneumologie, CHU du Point-G, E1631 Bamako, Mali
| | - G Berthé
- Service de pneumologie, CHU du Point-G, E1631 Bamako, Mali
| | - B Baya
- Service de pneumologie, CHU du Point-G, E1631 Bamako, Mali
| | - B Konaté
- Programme national de lutte contre la tuberculose (PNLT-Mali), Mali
| | - M Keita
- Maison centrale d'arrêt de Bamako (MCA), Bamako, Mali
| | - B Diarra
- Centre de formation et de recherche (SEREFO), Mali
| | - A Cissé
- Institut national de recherche en santé publique (INRSP), Mali
| | - F S Camara
- Institut national de recherche en santé publique (INRSP), Mali
| | - S Diallo
- Service de pneumologie, CHU du Point-G, E1631 Bamako, Mali; Centre de formation et de recherche (SEREFO), Mali
| |
Collapse
|
26
|
Kanté A, Ba B, Traoré D, Touré T, Daou M, Diakité S, Koné M, Mangané M, Tounkara I, Kéita M, Bengaly B, Coulibaly B, Togola B, Ouattara D, Diallo S, Sanogo S, Ongoïba N. [Brachial Plexus: Dissection At The Laboratory Of Anatomy Of Bamako]. Mali Med 2018; 33:6-9. [PMID: 35897235] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
INTRODUCTION The brachial plexus consists of the ventral twigs of the last four cervical nerves and the first thoracic nerve. It ensures the motor and sensitive innervations of the thoracic limb. AIM Our goal was to describe the brachial plexus of the cervical region to the middle third of the arm. METHODOLOGY We conducted a prospective study at the anatomy Laboratory of the Faculty of Medicine and Dentistry in Bamako from September 2016 to October 2017. We dissected the brachial plexus (PB) of 13 fresh adult corpses on both sides. The inclusion criteria were: Fresh adult corpses with cervical regions and brachial without scarring. The injected or scar-carrying corpses were not included in the cervical and brachial regions. RESULTS Twenty-six brachial plexus of which 18 bp in men and 8 bp in women were dissected. The average age of the subjects was 42 years (extreme: 18 and 70 years). We noted nerve block variations in 3.8%, fascicular in 3.8% and late terminal in 73.1%. The involvement of the anterior branch of the fourth spinal nerve (C4) was found in 46.2%. CONCLUSION The brachial plexus is the seat of many anatomical variations whose knowledge is indispensable to treat its lesions.
Collapse
|
27
|
Toloba Y, Soumaré D, Ouattara K, Kanouté T, Boré O, Dolo O, Baya B, Berthé G, Diallo S. [Respiratory diseases in black African carceral area]. Rev Mal Respir 2017; 34:729-733. [PMID: 28844810 DOI: 10.1016/j.rmr.2016.10.878] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2015] [Accepted: 10/26/2016] [Indexed: 11/24/2022]
Abstract
INTRODUCTION The measures for people in specific situations such as prisoners are part of the Millennium Development Goals (MDGs). The objective of this study was to assess respiratory pathologies in a black African carceral center. METHODS Retrospective study about the prevalence of respiratory pathologies in the arrest central house for men in Bamako (Mali), from May 2012 to April 2013. The admission records have served as data checking support on detainee's records. Statistical significance was investigated by the SAS 9.3 software with a threshold of 5%. RESULTS Of 2740 admissions, 207 concerned respiratory pathologies (7.5%). All men, were of mean age 30±13 years (range 19-71). The respiratory diseases found were: pneumonia (33.8%), chronic bronchitis (26.6%), acute respiratory infection (14%), asthma (13.5%) and tuberculosis (5.3%). A definite diagnosis was made in 42% of cases. A tobacco intoxication was found in all age groups (CI 95%, R-square=0.01), without significant difference between the occurrence of cough in smoking and non-smoking men. CONCLUSION According to their relative frequencies, the management of respiratory diseases requires collaboration between carceral health facilities and pneumological specialized services.
Collapse
Affiliation(s)
- Y Toloba
- Service de pneumologie, CHU de Point-G, Bamako, Mali.
| | - D Soumaré
- Service de pneumologie, CHU de Point-G, Bamako, Mali
| | - K Ouattara
- Service de pneumologie, CHU de Point-G, Bamako, Mali
| | - T Kanouté
- Service de pneumologie, CHU de Point-G, Bamako, Mali
| | - O Boré
- Maison centrale d'arrêt de Bamako, Bamako, Mali
| | - O Dolo
- Maison centrale d'arrêt de Bamako, Bamako, Mali
| | - B Baya
- Service de pneumologie, CHU de Point-G, Bamako, Mali
| | - G Berthé
- Service de pneumologie, CHU de Point-G, Bamako, Mali
| | - S Diallo
- Service de pneumologie, CHU de Point-G, Bamako, Mali
| |
Collapse
|
28
|
Keita A, Toure A, Sow M, Raoul H, Magassouba N, Delaporte E, Etard JF, Abel L, Ayouba A, Baize S, Bangoura K, Barry A, Barry M, Cissé M, Delaporte E, Delmas C, Desclaux A, Diallo S, Diallo M, Diallo M, Étard JF, Etienne C, Faye O, Fofana I, Granouillac B, Hébert E, Izard S, Kassé D, Keita A, Koivugui L, Kpamou C, Lacarabaratz C, Leroy S, Marchal C, Levy Y, Magassouba N, March L, Msellati P, Niane H, Peeters M, Pers YM, Raoul H, Sacko S, Savané I, Sow M, Taverne B, Touré A, Traoré F. Extraordinary long-term and fluctuating persistence of Ebola virus RNA in semen of survivors in Guinea: implications for public health. Clin Microbiol Infect 2017; 23:412-413. [DOI: 10.1016/j.cmi.2016.11.005] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2016] [Revised: 09/01/2016] [Accepted: 11/02/2016] [Indexed: 11/16/2022]
|
29
|
Sangaré SA, Maïga AI, Maïga A, Diallo S, Camara N, Savadogo S, Guindo I, Bougoudogo F, Armand-Lefèvre L, Andremont A, Maïga II. Prevalence of extended-spectrum beta-lactamase phenotypes in enterobacteria isolated from blood cultures of patients at admission to the University Hospital of Bamako. Med Sante Trop 2017; 27:170-175. [PMID: 28655678 DOI: 10.1684/mst.2017.0681] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
The aim of our study was to determine the frequency of extended-spectrum beta-lactamase (ESBL) phenotypes among the enterobacteria present in blood cultures of patients at admission to two university hospitals of Bamako (Mali). During a period of three months, we isolated enterobacteria from blood cultures from patients upon admission to the Point G and Gabriel Toure University Hospitals. The ESBL-positive enterobacteria were initially identified by API 20E strips and VITEK®2 and then confirmed in France by MALDI-TOF mass spectrometry at the Bichat Hospital bacteriology laboratory. Antibiotic susceptibility was determined by the diffusion method as recommended by EUCAST. The species isolated were K. pneumoniae (14/40, 35.0 %), E. coli (11/40, 27.5 %), and E. cloacae (9/40, 22.5 %); 21/34 (61.8 %) had an ESBL phenotype, including 10/14 (71.4 %) K. pneumoniae, 8/11 (72.7 %) E. coli, and 3/9 (33 3 %), E. cloacae. The ESBL strains of K. pneumoniae, E. coli, and E. cloacae were associated, respectively, with resistance to the following antibiotics: gentamicin (10/10, 100 %; 6/8, 75%; 2/3, 67%), amikacin (2/10, 20 %; 0/8, 0%; 0/3, 0%), ofloxacin (8/10, 80. %; 7/8, 87%; 3/3, 100%), cotrimoxazole (10/10, 100 %; 6/8, 75%; 3/3, 100%). Almost two thirds (61.8%) of the enterobacteria isolated from blood cultures produced extended-spectrum beta-lactamases. They retained regular sensitivity only to carbapenems and amikacin.
Collapse
Affiliation(s)
- S A Sangaré
- Laboratoire de bactériologie, CHU Gabriel Touré, Bamako, Mali, Laboratoire de bactériologie, CHU Bichat-Claude Bernard et UMR Inserm 1137 Iame Paris, France, Faculté de pharmacie (FAPH), Université des sciences des techniques, et des technologies de Bamako (USTTB), Bamako, Mali
| | - A I Maïga
- Laboratoire de bactériologie, CHU Gabriel Touré, Bamako, Mali, Faculté de pharmacie (FAPH), Université des sciences des techniques, et des technologies de Bamako (USTTB), Bamako, Mali
| | - A Maïga
- Laboratoire de bactériologie, CHU Point G, Bamako, Mali
| | - S Diallo
- Faculté de pharmacie (FAPH), Université des sciences des techniques, et des technologies de Bamako (USTTB), Bamako, Mali, Centre d'infectiologie Charles-Mérieux (CICM), Bamako, Mali
| | - N Camara
- Laboratoire de bactériologie, CHU Gabriel Touré, Bamako, Mali
| | - S Savadogo
- Laboratoire de bactériologie, CHU Point G, Bamako, Mali
| | - I Guindo
- Faculté de pharmacie (FAPH), Université des sciences des techniques, et des technologies de Bamako (USTTB), Bamako, Mali
| | - F Bougoudogo
- Faculté de pharmacie (FAPH), Université des sciences des techniques, et des technologies de Bamako (USTTB), Bamako, Mali
| | - L Armand-Lefèvre
- Laboratoire de bactériologie, CHU Bichat-Claude Bernard et UMR Inserm 1137 Iame Paris, France
| | - A Andremont
- Laboratoire de bactériologie, CHU Bichat-Claude Bernard et UMR Inserm 1137 Iame Paris, France
| | - I I Maïga
- Laboratoire de bactériologie, CHU Point G, Bamako, Mali, Faculté de médecine et d'odonto-stomatologie (FMOS), Université des sciences des techniques, et des technologies de Bamako (USTTB), Bamako, Mali
| |
Collapse
|
30
|
Kone B, Maiga M, Baya B, Sarro YDS, Coulibaly N, Kone A, Diarra B, Sanogo M, Togo ACG, Goita D, Dembele M, Polis MA, Warfield J, Belson M, Dao S, Orsega S, Murphy RL, Diallo S, Siddiqui S. Establishing Reference Ranges of Hematological Parameters from Malian Healthy Adults. J Blood Lymph 2017; 7:154. [PMID: 29423342 PMCID: PMC5800422 DOI: 10.4172/2165-7831.1000154] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
INTRODUCTION Measurement of immuno-hematological parameters has been historically helpful in the diagnosis and treatment monitoring of many infectious diseases and cancers. However, these parameters have not yet been established in many developing countries where patient care strongly relies on such low-cost tests. This study describes the immuno-hematological parameter ranges for Malian healthy adults. METHODS A cross sectional study was conducted from August 2004 to May 2013. We included 213 healthy volunteers (173 male and 40 female), aged between 18-59 years. Median, 2.5 and 97.5 percentile ranges for each immuno-hematological parameter are presented. RESULTS In our study population, the hematological parameters' ranges were mostly different to the universal established ranges. We found in our population a Median white blood cell (WBC) count of 5200 cells/μL [3237.5-11900], Red Blood Cell (RBC) count of 4.94 10^6 [3.56-6.17], hemoglobin (Hb) of 14.2 g/dL [12.2-17.38], platelet count (Plt) of 275 10^3/μL [145.4-614.4], lymphocytes 2050/μL [1200-3800], neutrophils 2200/μL [1040-6220]; monocytes 200/μL [100-660]; eosinophils 131/μL [0-1026]; CD4 902 cells/μL [444-1669] and CD8 485 cells/μL [0-1272]. We found significant gender differences in RBC, Hb level and MPV. However, RBC and Hb were higher in males median values compared to females (median values) (p<0.001), whereas the Mean platelet volume lower values (MPV) in males than females (P<0.047). The hemoglobin level for some West African countries (Mali, Burkina Faso, Togo, and Nigeria) ranged from 13.5 to 15.1 g/dL for males and 12 to 13 g/dL for females. However in East and Southern Africa, the values were anywhere from 14.1 to 16.1 for males and 11.2 to 14.4 for females. CONCLUSION Our data may help physicians to better define hematological abnormalities in patients. They may also be used to define new "normal hematological values" in Malian population or in the whole West African population.
Collapse
Affiliation(s)
- B Kone
- University of Sciences, Techniques and Technologies of Bamako, Mali
| | - M Maiga
- University of Sciences, Techniques and Technologies of Bamako, Mali
- Leidos Biomedical Research, Inc., in support to NIAID, Bethesda, Maryland, USA
- Northwestern University, Chicago, Illinois, USA
| | - B Baya
- University of Sciences, Techniques and Technologies of Bamako, Mali
| | - YDS Sarro
- University of Sciences, Techniques and Technologies of Bamako, Mali
| | - N Coulibaly
- University of Sciences, Techniques and Technologies of Bamako, Mali
| | - A Kone
- University of Sciences, Techniques and Technologies of Bamako, Mali
| | - B Diarra
- University of Sciences, Techniques and Technologies of Bamako, Mali
| | - M Sanogo
- University of Sciences, Techniques and Technologies of Bamako, Mali
| | - ACG Togo
- University of Sciences, Techniques and Technologies of Bamako, Mali
| | - D Goita
- University of Sciences, Techniques and Technologies of Bamako, Mali
| | - M Dembele
- University of Sciences, Techniques and Technologies of Bamako, Mali
| | - MA Polis
- National Institute of Allergic and Infectious Diseases (NIAID), Bethesda, Maryland, USA
| | - J Warfield
- Leidos Biomedical Research, Inc., in support to NIAID, Bethesda, Maryland, USA
| | - M Belson
- National Institute of Allergic and Infectious Diseases (NIAID), Bethesda, Maryland, USA
| | - S Dao
- University of Sciences, Techniques and Technologies of Bamako, Mali
| | - S Orsega
- National Institute of Allergic and Infectious Diseases (NIAID), Bethesda, Maryland, USA
| | - RL Murphy
- Northwestern University, Chicago, Illinois, USA
| | - S Diallo
- University of Sciences, Techniques and Technologies of Bamako, Mali
| | - S Siddiqui
- National Institute of Allergic and Infectious Diseases (NIAID), Bethesda, Maryland, USA
| |
Collapse
|
31
|
Ndiaye M, Taleb M, Diatta B, Diop A, Diallo M, Diadie S, Seck N, Diallo S, Ndiaye M, Niang S, Ly F, Kane A, Dieng M. Les étiologies des intertrigos chez l’adulte : étude prospective de 103 cas. J Mycol Med 2017; 27:28-32. [DOI: 10.1016/j.mycmed.2016.06.001] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2016] [Revised: 05/29/2016] [Accepted: 06/01/2016] [Indexed: 01/12/2023]
|
32
|
Sanogo M, Kone B, Diarra B, Maiga M, Baya B, Somboro AM, Sarro YS, Togo ACG, Dembele BPP, Goita D, Kone A, M'Baye O, Coulibaly N, Diabate S, Traore B, Diallo MH, Coulibaly YI, Saleeb P, Belson M, Orsega S, Siddiqui S, Polis MA, Dao S, Murphy RL, Diallo S. Performance of microscopic observation drug susceptibility for the rapid diagnosis of tuberculosis and detection of drug resistance in Bamako, Mali. Clin Microbiol Infect 2017; 23:408.e1-408.e6. [PMID: 28110049 DOI: 10.1016/j.cmi.2017.01.004] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2016] [Revised: 11/08/2016] [Accepted: 01/04/2017] [Indexed: 01/01/2023]
Abstract
OBJECTIVES In Mali early detection and treatment of multidrug-resistant tuberculosis (MDR-TB) are still challenging due to the cost, time and/or complexity associated with regular tests. Microscopic Observation Drug Susceptibility (MODS) is a low-cost assay validated by WHO in 2010. It is a liquid-culture-based assay to detect the 'cording' characteristic of Mycobacterium tuberculosis complex and to assess susceptibility to both isoniazid and rifampicin defining multidrug-resistant tuberculosis (MDR-TB). In this study we aimed to evaluate the performance of MODS as diagnostic tool compared with a validated method-Mycobacteria Growth Indicator Tube/Antimicrobial Susceptibility Testing/Streptomycin, Isoniazid, Rifampicin and Ethambutol (MGIT/AST/SIRE). METHODS AND RESULTS Between January 2010 and October 2015 we included 98 patients with suspected TB in an observational cohort study. The sensitivity and specificity of MODS assay for detecting TB were respectively 94.12% and 85.71% compared with the reference MGIT/7H11 culture, with a Cohen κ coefficient of 0.78 (95% CI 0.517-1.043). The median time to culture positivity for MODS assay and MGIT (plus interquartile range, IQR) was respectively 8 days (IQR 5-11) and 6 days (IQR 5-6). In detecting patients with MDR-TB, the sensitivity and specificity of MODS assay were respectively 100% and 95.92%. The positive predictive value and negative predictive value were, respectively, 66.7% and 100%. The median turnaround times for obtaining MDR-TB results using MODS assay and MGIT/AST/SIRE was respectively 9 days and 35 days. Hence, the MODS assay rapidly identifies MDR-TB in Mali compared with the MGIT/AST/SIRE. CONCLUSION As an easy, simple, fast and affordable method, the MODS assay could significantly improve the management of TB.
Collapse
Affiliation(s)
- M Sanogo
- SEREFO Laboratories of the University Clinical Research Centre, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - B Kone
- SEREFO Laboratories of the University Clinical Research Centre, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - B Diarra
- SEREFO Laboratories of the University Clinical Research Centre, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali; Institute of Tropical Medicine (ITM), Biomedical Department, Antwerp, Belgium.
| | - M Maiga
- SEREFO Laboratories of the University Clinical Research Centre, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali; Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc., NCI Campus at Frederick, Frederick, MD, USA
| | - B Baya
- SEREFO Laboratories of the University Clinical Research Centre, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - A M Somboro
- SEREFO Laboratories of the University Clinical Research Centre, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - Y S Sarro
- SEREFO Laboratories of the University Clinical Research Centre, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - A C G Togo
- SEREFO Laboratories of the University Clinical Research Centre, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - B P P Dembele
- SEREFO Laboratories of the University Clinical Research Centre, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - D Goita
- SEREFO Laboratories of the University Clinical Research Centre, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - A Kone
- SEREFO Laboratories of the University Clinical Research Centre, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - O M'Baye
- SEREFO Laboratories of the University Clinical Research Centre, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - N Coulibaly
- SEREFO Laboratories of the University Clinical Research Centre, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - S Diabate
- SEREFO Laboratories of the University Clinical Research Centre, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - B Traore
- SEREFO Laboratories of the University Clinical Research Centre, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - M H Diallo
- SEREFO Laboratories of the University Clinical Research Centre, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - Y I Coulibaly
- Filariasis Unit of the Malaria Research and Training Centre (MRTC), USTTB, Bamako, Mali
| | - P Saleeb
- University of Maryland School of Medicine, Baltimore, MD, USA
| | - M Belson
- Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
| | - S Orsega
- Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
| | - S Siddiqui
- Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
| | - M A Polis
- Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
| | - S Dao
- SEREFO Laboratories of the University Clinical Research Centre, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - R L Murphy
- Division of Infectious Diseases, Northwestern University, Chicago, IL, USA
| | - S Diallo
- SEREFO Laboratories of the University Clinical Research Centre, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| |
Collapse
|
33
|
Soumaré DDN, Outtara K, Kanouté T, Toloba Y, Baya B, Diallo S. Aspect épidémiologiques et histopathologiques des cancers broncho-pulmonaires au Mali au cours d’une décennie : données du registre des cancers. Rev Mal Respir 2017. [DOI: 10.1016/j.rmr.2016.10.194] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
34
|
Toloba Y, Kanouté T, Soumaré D, Ouattara K, Kamian Y, Baya B, M’Baye O, Berthé G, Diabaté S, Diallo S. Motif d’hospitalisation des cas de TPM+ en milieu hospitalier phtisiologique. Rev Mal Respir 2017. [DOI: 10.1016/j.rmr.2016.10.548] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
35
|
Toloba Y, Cissé A, Soumaré D, Ouattara K, Kanouté T, Koné D, Diarra B, Baya B, Berthé G, Camara F, Konaté B, Diallo S. Apport du GeneXpert dans le diagnostic de la tuberculose et de la résistance à la rifampicine au Mali après 22 mois d’acquisition. Rev Mal Respir 2017. [DOI: 10.1016/j.rmr.2016.10.515] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
36
|
Diatta BA, Diallo M, Diadie S, Faye B, Ndiaye M, Diallo S, Seck B, Niang SO, Kane A, Tieng MT. Une leishmaniose cutanée à Leishmania infantum associée à une infection par le VIH. Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.103] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
37
|
Diarra B, Goita D, Tounkara S, Sanogo M, Baya B, Togo ACG, Maiga M, Sarro YS, Kone A, Kone B, M'Baye O, Coulibaly N, Kassambara H, Cisse A, Belson M, Polis MA, Otu J, Gehre F, Antonio M, Dao S, Siddiqui S, Murphy RL, de Jong BC, Diallo S. Tuberculosis drug resistance in Bamako, Mali, from 2006 to 2014. BMC Infect Dis 2016; 16:714. [PMID: 27894266 PMCID: PMC5126865 DOI: 10.1186/s12879-016-2060-7] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2016] [Accepted: 11/22/2016] [Indexed: 12/02/2022] Open
Abstract
Background Although Drug resistance tuberculosis is not a new phenomenon, Mali remains one of the “blank” countries without systematic data. Methods Between 2006 and 2014, we enrolled pulmonary TB patients from local TB diagnostics centers and a university referral hospital in several observational cohort studies. These consecutive patients had first line drug susceptibility testing (DST) performed on their isolates. A subset of MDR was subsequently tested for second line drug resistance. Results A total of 1186 mycobacterial cultures were performed on samples from 522 patients, including 1105 sputa and 81 blood samples, yielding one or more Mycobacterium tuberculosis complex (Mtbc) positive cultures for 343 patients. Phenotypic DST was performed on 337 (98.3%) unique Mtbc isolates, of which 127 (37.7%) were resistant to at least one drug, including 75 (22.3%) with multidrug resistance (MDR). The overall prevalence of MDR-TB was 3.4% among new patients and 66.3% among retreatment patients. Second line DST was available for 38 (50.7%) of MDR patients and seven (18.4%) had resistance to either fluoroquinolones or second-line injectable drugs. Conclusion The drug resistance levels, including MDR, found in this study are relatively high, likely related to the selected referral population. While worrisome, the numbers remained stable over the study period. These findings prompt a nationwide drug resistance survey, as well as continuous surveillance of all retreatment patients, which will provide more accurate results on countrywide drug resistance rates and ensure that MDR patients access appropriate second line treatment. Electronic supplementary material The online version of this article (doi:10.1186/s12879-016-2060-7) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- B Diarra
- SEREFO Program, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali. .,Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
| | - D Goita
- SEREFO Program, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - S Tounkara
- SEREFO Program, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - M Sanogo
- SEREFO Program, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - B Baya
- SEREFO Program, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - A C G Togo
- SEREFO Program, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - M Maiga
- SEREFO Program, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - Y S Sarro
- SEREFO Program, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - A Kone
- SEREFO Program, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - B Kone
- SEREFO Program, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - O M'Baye
- SEREFO Program, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - N Coulibaly
- SEREFO Program, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - H Kassambara
- SEREFO Program, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - A Cisse
- Laboratoire National de Référence des Mycobactéries (LNR), Institut National de Recherche en Santé publique (INRSP), Bamako, Mali
| | - M Belson
- CCRB, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
| | - M A Polis
- CCRB, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
| | - J Otu
- Vaccines and Immunity Theme, Atlantic Boulevard, Medical Research Council (MRC), Fajara, Banjul, The Gambia
| | - F Gehre
- Vaccines and Immunity Theme, Atlantic Boulevard, Medical Research Council (MRC), Fajara, Banjul, The Gambia.,Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium
| | - M Antonio
- Vaccines and Immunity Theme, Atlantic Boulevard, Medical Research Council (MRC), Fajara, Banjul, The Gambia.,Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.,Microbiology and Infection Unit, Warwick Medical School, University of Warwick, Coventry, UK
| | - S Dao
- SEREFO Program, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| | - S Siddiqui
- CCRB, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
| | - R L Murphy
- Global Health, Northwestern University, Chicago, IL, USA
| | - B C de Jong
- Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium
| | - S Diallo
- SEREFO Program, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
| |
Collapse
|
38
|
Ouedraogo E, Lurton G, Mohamadou S, Dillé I, Diallo I, Mamadou S, Adehossi E, Hanki Y, Tchousso O, Arzika M, Gazeré O, Amadou F, Illo N, Abdourahmane Y, Idé M, Alhousseini Z, Lamontagne F, Deze C, D'Ortenzio E, Diallo S. [Evaluation of the benefit of different complementary exams in the search for a TB diagnosis algorithm for HIV patients put on ART in Niamey, Niger]. ACTA ACUST UNITED AC 2016; 109:368-375. [PMID: 27848101 DOI: 10.1007/s13149-016-0532-z] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2015] [Accepted: 06/30/2016] [Indexed: 11/25/2022]
Abstract
In Niger, the tuberculosis (TB) screening among people living with human immunodeficiency virus (HIV) (PLHIV) is nonsystematic and the use of additional tests is very often limited. The objective of this research is to evaluate the performance and the cost-effectiveness of various paraclinical testing strategies of TB among adult patients with HIV, using available tests in routine for patients cared in Niamey. This is a multicentric prospective intervention study performed in Niamey between 2010 and 2013. TB screening has been sought in newly diagnosed PLHIV, before ART treatment, performing consistently: a sputum examination by MZN (Ziehl-Nielsen staining) and microscopy fluorescence (MIF), chest radiography (CR), and abdominal ultrasound. The performance of these different tests was calculated using sputum culture as a gold standard. The various examinations were then combined in different algorithms. The cost-effectiveness of different algorithms was assessed by calculating the money needed to prevent a patient, put on ART, dying of TB. Between November 2010 and November 2012, 509 PLHIV were included. TB was diagnosed in 78 patients (15.3%), including 35 pulmonary forms, 24 ganglion, and 19 multifocal. The sensitivity of the evaluated algorithms varied between 0.35 and 0.85. The specificity ranged from 0.85 to 0.97. The most costeffective algorithm was the one involving MIF and CR. We recommend implementing a systematic and free direct examination of sputum by MIF and a CR for the detection of TB among newly diagnosed PLHIV in Niger.
Collapse
Affiliation(s)
| | | | | | - I Dillé
- Ministère de la Santé publique du Niger, Niamey, Niger
| | | | - S Mamadou
- Ministère de la Santé publique du Niger, Niamey, Niger.,Université de Niamey, Niamey, Niger
| | - E Adehossi
- Ministère de la Santé publique du Niger, Niamey, Niger.,Université de Niamey, Niamey, Niger
| | - Y Hanki
- Ministère de la Santé publique du Niger, Niamey, Niger
| | - O Tchousso
- Ministère de la Santé publique du Niger, Niamey, Niger
| | - M Arzika
- Ministère de la Santé publique du Niger, Niamey, Niger
| | - O Gazeré
- Ministère de la Santé publique du Niger, Niamey, Niger
| | - F Amadou
- Ministère de la Santé publique du Niger, Niamey, Niger
| | - N Illo
- Ministère de la Santé publique du Niger, Niamey, Niger
| | | | - M Idé
- Ministère de la Santé publique du Niger, Niamey, Niger
| | - Z Alhousseini
- Coordination intersectorielle de lutte contre les IST/VIH/sida de Niamey, Niamey, Niger
| | | | - C Deze
- Solthis, 75013, Paris, France
| | | | | |
Collapse
|
39
|
Sangare SA, Maiga AI, Guindo I, Maiga A, Camara N, Savadogo S, Diallo S, Bougoudogo F, Armand-Lefevre L, Andremont A, Maiga II. Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated from blood cultures in Africa. Med Mal Infect 2016; 45:374-82. [PMID: 26433872 DOI: 10.1016/j.medmal.2015.08.003] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2015] [Revised: 06/09/2015] [Accepted: 08/31/2015] [Indexed: 11/15/2022]
Abstract
Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae have been isolated from many regions of the world. Epidemiological studies are being conducted in Europe, North America, and Asia. No study has however been conducted in Africa to determine the prevalence and distribution of ESBLs on the continent. This literature review aimed at describing the prevalence of ESBL-producing Enterobacteriaceae isolated from blood cultures, as well as the ESBL genes involved at the international level. Our focus was mainly on Africa. We conducted a literature review on PubMed. Articles related to our study field and published between 1996 and 2014 were reviewed and entirely read for most of them, while we only focused on the abstracts of some other articles. Relevant articles to our study were then carefully reviewed and included in the review. The prevalence of ESBL-producing Enterobacteriaceae differs from one country to another. The results of our literature review however indicate that class A ESBLs prevail over the other types. We took into consideration articles focusing on various types of samples to assess the prevalence of ESBL-producing Enterobacteriaceae, but information on isolates from blood cultures is limited. The worldwide prevalence of ESBL-producing Enterobacteriaceae has increased over time. Evidence of ESBL-producing Enterobacteriaceae can be found in all regions of the world. Studies conducted in Africa mainly focused on the Northern and Eastern parts of the continent, while only rare studies were carried out in the rest of the continent.
Collapse
Affiliation(s)
- S A Sangare
- Laboratory of bacteriology, university hospital Gabriel-Touré, Bamako, Mali; Laboratory of bacteriology, university hospital Bichat-Claude Bernard and UMR Inserm 1137 Iame, 46, rue Henri-Huchard, 75018 Paris, France; Faculty of pharmacy, university of sciences, techniques, and technologies of Bamako (USTTB), Bamako, Mali.
| | - A I Maiga
- Laboratory of bacteriology, university hospital Gabriel-Touré, Bamako, Mali; Faculty of pharmacy, university of sciences, techniques, and technologies of Bamako (USTTB), Bamako, Mali
| | - I Guindo
- Faculty of pharmacy, university of sciences, techniques, and technologies of Bamako (USTTB), Bamako, Mali; National institute for research in public health, Bamako, Mali
| | - A Maiga
- Laboratory of bacteriology, university hospital Point G, Bamako, Mali
| | - N Camara
- Laboratory of bacteriology, university hospital Gabriel-Touré, Bamako, Mali
| | - S Savadogo
- Laboratory of bacteriology, university hospital Point G, Bamako, Mali
| | - S Diallo
- Faculty of pharmacy, university of sciences, techniques, and technologies of Bamako (USTTB), Bamako, Mali; Infectious diseases center "Charles Mérieux", Bamako, Mali
| | - F Bougoudogo
- Faculty of pharmacy, university of sciences, techniques, and technologies of Bamako (USTTB), Bamako, Mali; National institute for research in public health, Bamako, Mali
| | - L Armand-Lefevre
- Laboratory of bacteriology, university hospital Bichat-Claude Bernard and UMR Inserm 1137 Iame, 46, rue Henri-Huchard, 75018 Paris, France
| | - A Andremont
- Laboratory of bacteriology, university hospital Bichat-Claude Bernard and UMR Inserm 1137 Iame, 46, rue Henri-Huchard, 75018 Paris, France
| | - I I Maiga
- Laboratory of bacteriology, university hospital Point G, Bamako, Mali; Faculty of medicine and odonto-stomatology, university of sciences, techniques, and technologies of Bamako (USTTB), Bamako, Mali
| |
Collapse
|
40
|
Diadie S, Diatta B, Ndiaye M, Gaye M, Sow D, Ndiaye MT, Seck B, Diallo S, Diop A, Diallo M, Ly F, Niang SO, Kane A, Dieng MT. [Multifocal histoplasmosis due to Histoplasma capsulatum var. duboisii in a 22 year-old Senegalese patient without proven immunodepression]. J Mycol Med 2016; 26:265-70. [PMID: 27158080 DOI: 10.1016/j.mycmed.2016.03.004] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2015] [Revised: 03/03/2016] [Accepted: 03/30/2016] [Indexed: 10/21/2022]
Abstract
The authors report a case of multifocal African histoplasmosis with polymorphic skin involvement occuring in a patient without proven immunosuppression. He was a young 22-year-old patient from eastern Senegal - but born in Ouganda - who presented with polymorphic skin lesions: ombilicated papulo-nodules, gums and ulcerative and budding lesions. He showed lymphadenopathies without clinical inflammation and with a cheesy appearance of the biopsy but without tuberculosis and also hepatosplenic and bone involvement. Mycological samples of the skin and lymph nodes biopsies revealed yeasts of Histoplasma capsulatum var. duboisii with a positive culture on Sabouraud medium. HIV serology, HTLV1et 2, the serum proteins electrophoresis were unremarkable. Treatment with amphotericin B was irregular because of its inaccessibility in the national territory and its cost. The patient died of sepsis together with the aggravation of his disease.
Collapse
Affiliation(s)
- S Diadie
- Service de dermatologie, l'hôpital Aristide-Le-Dantec, Dakar, Sénégal.
| | - B Diatta
- Service de dermatologie, l'hôpital Aristide-Le-Dantec, Dakar, Sénégal.
| | - M Ndiaye
- Service de dermatologie, l'hôpital Aristide-Le-Dantec, Dakar, Sénégal.
| | - M Gaye
- Service d'anatomopathologie de l'hôpital Aristide-Le-Dantec, Dakar, Sénégal.
| | - D Sow
- Service de parasitologie, CHNU Fann-Dakar, Dakar, Sénégal.
| | - M T Ndiaye
- Service de dermatologie, l'hôpital Aristide-Le-Dantec, Dakar, Sénégal.
| | - B Seck
- Service de dermatologie, l'hôpital Aristide-Le-Dantec, Dakar, Sénégal.
| | - S Diallo
- Service de dermatologie, l'hôpital Aristide-Le-Dantec, Dakar, Sénégal.
| | - A Diop
- Service de dermatologie, l'hôpital Aristide-Le-Dantec, Dakar, Sénégal.
| | - M Diallo
- Service de dermatologie, l'hôpital Aristide-Le-Dantec, Dakar, Sénégal.
| | - F Ly
- Service de dermatologie, l'hôpital Aristide-Le-Dantec, Dakar, Sénégal.
| | - S O Niang
- Service de dermatologie, l'hôpital Aristide-Le-Dantec, Dakar, Sénégal.
| | - A Kane
- Service de dermatologie, l'hôpital Aristide-Le-Dantec, Dakar, Sénégal.
| | - M T Dieng
- Service de dermatologie, l'hôpital Aristide-Le-Dantec, Dakar, Sénégal.
| |
Collapse
|
41
|
Seck N, Diadié S, Fall B, Diatta B, Diallo S, Diallo M, Niang S, Kane A, Dieng M. F14 : La fièvre méditerranéenne familiale ou maladie périodique : une observation à type de panniculite. Ann Dermatol Venereol 2016. [DOI: 10.1016/s0151-9638(16)30121-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
42
|
Diallo M, Diatta B, Diop A, Seck N, Tine M, Diadie S, Diallo S, Seck B, Ly F, Niang S, Kane A, Dieng M. P 71 : Spectre des lymphomes cutanés au Sénégal : Etude transversale sur 14 ans. Ann Dermatol Venereol 2016. [DOI: 10.1016/s0151-9638(16)30246-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
43
|
Diallo M, Toure M, Diatta B, Diop A, Ndiaye M, Seck N, Diadié S, Diallo S, Diop T, Seck B, Niang S, Ly F, Kane A, Dieng M. CO 41 : Evaluation de la rigidité artérielle par popmetre chez des sujets noirs africains atteints de sclérodermie systémique. Ann Dermatol Venereol 2016. [DOI: 10.1016/s0151-9638(16)30168-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
44
|
Diatta B, Niang S, Keita F, ly F, Mbengue N, Diallo M, diaye N, Diop A, Diouf A, Seck N, Diallo S, Diadié S, Ndiaye M, Seck B, Kane A, Dieng M. CO 34 : Les Toxidermies à Dakar : Étude de 200cas sur une période de 14 ans. Ann Dermatol Venereol 2016. [DOI: 10.1016/s0151-9638(16)30161-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
45
|
Diallo M, Zineb K, Diatta A, Ndiaye M, Diop A, Seck N, Tine M, Diadie S, Diallo S, Seck B, Ly F, Niang S, Kane A, Dieng M. CO 30 : Alopécie cicatricielle centrale centrifuge chez la femme africaine : aspects épidémiologiques et cliniques, facteurs de risque et influence génétique. Ann Dermatol Venereol 2016. [DOI: 10.1016/s0151-9638(16)30157-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
46
|
Diadie S, Diatta B, Ndiaye M, Gaye M, Doudou S, Ndiaye M, Seck B, Diallo S, Diop, Diallo M, Ly F, Niang S, Kane A, Dieng M. F16 : Histoplasmose multifocale à Histoplasma capsulatum var duboisii chez un Sénégalais de 22 ans sans immunodépression prouvée. Ann Dermatol Venereol 2016. [DOI: 10.1016/s0151-9638(16)30123-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
47
|
Diatta B, Niang S, ly F, Diallo M, diaye N, Diop A, Diouf A, Hakim H, Seck N, Diallo S, Diadié S, Ndiaye M, Seck B, Kane A, Dieng M. P 45 : Manifestations Dermatologiques de la maladie lupique : Etude de 340 cas sur une période de 16 ans. Ann Dermatol Venereol 2016. [DOI: 10.1016/s0151-9638(16)30220-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
48
|
Diallo M, Ndiaye M, Diop A, Diatta B, Tine M, Seck N, Diadie S, Diallo S, Seck B, Ly F, Niang S, Kane A, Dieng M. CO 48 : Profil épidémiologique et anatomo-clinique des cancers cutanés au CHU Aristide Le Dantec de Dakar sur une période de 10 ans. Ann Dermatol Venereol 2016. [DOI: 10.1016/s0151-9638(16)30175-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
49
|
Diatta B, Niang V, Kane A, Ndiaye M, Diallo M, Diop A, Diouf A, Seck N, Diallo S, Diadié S, Ndiaye M, Seck B, Niang S, Dieng M. P 49 : Ichtyose héréditaire à Dakar : Aspects épidémiologiques, cliniques et évolutifs sur une période de 10 ans. Ann Dermatol Venereol 2016. [DOI: 10.1016/s0151-9638(16)30224-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
50
|
Diadié S, Diatta B, Ndiaye M, Gaye M, Sow D, Ndiaye M, Seck B, Diallo S, Diop A, Diallo M, ly F, Niang S, Kane A, Dieng M. P 15 : Histoplasmose africaine multifocale avec atteinte cutanée survenant chez un sénégalais immuno compétent. Ann Dermatol Venereol 2016. [DOI: 10.1016/s0151-9638(16)30190-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|